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ABSTRACT 
Effects of Dietary Fat and Fiber on the Oxidative Status of the Small Intestine and Colon 
of Rats.  (May 2005) 
Lisa Merle Sanders, B.S., Texas A&M University 
Chair of Advisory Committee:  Dr. Joanne R. Lupton 
 
 
 
Colon cancer is one of the most commonly diagnosed cancers in the US, yet 
small intestine cancer is a rare event.  While there are many similarities between these 
two tissues, inherent differences such as redox status, may contribute to the variation in 
cancer occurrence.  We examined the difference in reactive oxygen species (ROS) 
generation, antioxidant enzyme activity and oxidative DNA damage in the small and 
large intestine of rats under normal conditions and following exposure to exogenous 
oxidative stress.  Basal ROS and antioxidant enzyme activities were greater in the colon 
than the small intestine, and the balance of ROS to antioxidant enzymes in the colon was 
more pro-oxidant than in the small intestine.  During oxidative stress, ROS and oxidative 
DNA damage were greater in the colon than the small intestine.  Thus the colon 
responds to oxidative stress less effectively than the small intestine, possibly 
contributing to increased cancer incidence at this site.  We next wanted to understand 
how diets containing a combination of fish or corn oil and pectin or cellulose may alter 
the redox environment of the colon.  ROS, oxidative DNA damage, antioxidant enzyme 
activity and apoptosis were measured in colonocytes of rats fed one of four diets 
containing either corn oil or fish oil and cellulose or pectin.  Measurements were made 
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in rats untreated with carcinogen and rats exposed to a chemical carcinogen and 
radiation.   In rats not treated with a carcinogen, fish oil enhanced ROS, and fish 
oil/pectin suppressed antioxidant enzymes as compared to corn oil/cellulose.  Oxidative 
DNA damage was inversely related to ROS in the fish oil/pectin diet and apoptosis was 
enhanced relative to other diets.  In carcinogen treated and irradiated rats, a similar 
protective effect was seen with fish oil/pectin as evidenced by a reduction in oxidative 
DNA damage and enhancement of apoptosis.  This suggests that a diet containing fish 
oil/pectin may protect against colon carcinogenesis by modulation of the redox 
environment to promote apoptosis and minimize oxidative DNA damage. 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
 
Intestinal Physiology and Carcinogenesis 
Cancer statistics.  One of the greatest public health concerns in developed 
countries, including the United States, is cancer.  Of all cancers, colon cancer is the third 
most commonly diagnosed and it is estimated that almost 57,000 Americans will die 
from the disease this year.  Furthermore, colon cancer diagnosis and mortality rates are 
almost equal for men and women, unlike breast and prostate cancer, which are gender 
specific (1).  Worldwide, colon cancer incidence varies widely.  Incident rates in the 
United Sates and northern Europe are almost 10-fold more than southern Europe, Asia 
and Africa.  Furthermore, individuals migrating from low to high-incidence areas show 
increased rates of colon cancer, indicating the strong influence of environmental factors 
on colon cancer occurrence (2). 
In the United States, for every 28 cases of colorectal cancer reported, there is 
only one case of small intestine cancer (1).   Nevertheless, epidemiological evidence 
suggests a strong correlation between colon cancer and small intestine cancer incidence 
(3).  While investigations into the etiology of small intestine cancer are few due to the 
rarity of the disease, it does appear that the same environmental factors which influence 
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colon cancer incidence also impact small intestine cancer incidence and to a similar 
magnitude (4). 
 
Physiology of the small and large intestine.  The small and large intestine 
comprise approximately 8 m of the 9 m-long alimentary canal (5).  The majority of this 
length (6 m) is the small intestine which begins at the pyloric sphincter of the stomach 
and coils within the abdominal cavity until it joins the large intestine at the ileocecal 
valve.  The large intestine, so named as it is larger in diameter than the small intestine, is 
the remaining 1.5-2 m. 
The small intestine is divided into three major sections:  the duodenum, the 
jejunum and the ileum.  The duodenum is the first section of the small intestine 
immediately following the stomach.  The majority of absorption as well as the 
introduction of secretions from the pancreas and liver occur within this 25 cm region.  
The duodenum is followed by the jejunum and the ileum which show little structural 
change besides a thinning of the intestinal wall.  Absorption continues throughout these 
portions so much that there is very little absorbable material that passes from the ileum 
into the large intestine. 
The large intestine consists of the cecum, colon, rectum, and anal canal.  Of these 
sections, the colon makes up the majority of the length and surface area.  Compared to 
the small intestine, minimal digestion occurs in the colon and absorption is primarily 
limited to water and electrolytes.  Additionally, the colon contains microflora which can 
digest and/or ferment materials, such as fiber, that are unable to be broken down by 
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intestinal enzymes.  Products of this microbial degradation include vitamins, such as 
vitamin K, and short chain fatty acids, such as butyrate, which can then be absorbed for 
utilization by the body or the colon cells. 
The walls of the intestine are made up of four distinct layers, each with their own 
unique function.  The serosal layer is the outermost covering of the intestine which 
protects the intestine from the peritoneal environment and lubricates the surface so as to 
ease movement against neighboring organs.  The muscular layer is responsible for the 
movement of the intestinal walls which aids in transit and digestion of the luminal 
contents.  In the small intestine, circular fibers are used to contract the diameter of the 
intestine, while longitudinal fibers shorten the length.  The colon contains only 
longitudinal fibers arranged in bands which give the colon its pouch-like appearance.   
The submucosa consists primarily of loose connective tissue, but also contains glands, 
lymphatic vessels and blood vessels responsible for nourishing the intestinal wall as well 
as removing absorbed materials.  The innermost layer of the intestinal wall is the 
mucosal layer, which actually consists of sub-layers of smooth muscle, connective tissue 
(lamina propria) and epithelium.  It is within this layer that most enzyme and mucous 
secretion as well as absorption occur (5). 
The epithelium is organized into small invaginations referred to as crypts.  The 
crypt formation allows for increased surface area to enhance absorption.  As the small 
intestine is the primary site for absorption of nutrients contained in food, the epithelium 
of the small intestine also contains villi.  These finger-like projections extend from the 
crypt into the lumen, further increasing surface area.  Lining the crypts and villi is a 
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single layer of epithelial cells, responsible for most of the secretory, absorptive and 
barrier functions of the intestine. These epithelial cells are self-renewing and maintain a 
highly-controlled balance of cell proliferation and cell death (6).  It is the perturbation of 
this balance that can lead to malignant transformation and tumorigenesis.  
Carcinogenic transformation of intestinal epithelial cells.  Carcinogenesis in 
humans is a multi-step process, evolving over many years, that results in the culmination 
of multiple genetic mutations which transform normal intestinal epithelial cells to a 
malignant phenotype.  This malignant phenotype is characterized initially by the cell’s 
ability to proliferate indefinitely, generate its own growth signals, resist anti-growth 
signals and evade apoptosis (programmed cell death).  At later stages, tumor cells 
acquire the ability to induce and sustain vascularization and eventually succeed in tissue 
invasion and metastasis (7).  The genetic alterations leading to this carcinogenic 
transformation involve the mutational activation of oncogenes as well as the loss of 
function of tumor suppressor genes (8).  Mutations in several of these genes are required 
to fully induce the malignant phenotype and in colon cancer these mutations generally 
accumulate sequentially through three distinct stages:  initiation, promotion and 
progression.   
During initiation, DNA can suffer several forms of damage ranging from base 
modification by oxidation or alkylation to single or double strand breaks.  Modification 
of DNA bases can lead to mismatches during gene expression and DNA replication, 
which if left unrepaired, can lead to mutations (9).  The consequences of single and 
double strand breaks may even be more severe as the repair process is extremely error-
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prone (10).   The DNA mutations sustained during the initiation stage are often the 
genetic alterations responsible for the hyperproliferation and resistance to apoptosis seen 
in the promotion stage of colon carcinogenesis.  At this stage, microscopic changes in 
crypt morphology become apparent in the formation of aberrant crypts.  Often these 
aberrant crypts are seen clustered together in the colon, and these areas have been 
considered by some to be precursor lesions to colon tumors (11,12).  Evidence suggests 
that only a fraction of aberrant crypts will continue on to form tumors (12) and this may 
be due to the continued accumulation of genetic mutations which offer a growth 
advantage toward the tumor progression stage.  During progression, tumor formation is 
apparent as is evidence of malignancy, such as increased angiogenesis.  Once the tumor 
begins invasion of the submucosa of the intestine, it is termed a carcinoma (8).  At this 
point, multiple genetic mutations have occurred, giving rise to the characteristics 
indicative of cancer:  limitless cellular replication, resistance to apoptosis, self-sustained 
growth and ability to ignore anti-growth signals, enhanced vascularization and tissue 
invasion (7). 
In colon cancer, there are a number of genes which are frequently found to be 
mutated.  One of the most common mutations, generally found early in the carcinogenic 
sequence, occurs in the adenomatous polyposis coli (APC) tumor suppressor gene.  This 
gene functions as a regulator of cell proliferation, but may also play roles in apoptosis 
and cell migration (12).  Mutation of this gene product results in epithelial cell 
hyperproliferation and the formation of adenomas which have the potential to progress 
into tumors.  Other mutations frequently found later in the carcinogenic process involve 
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the genes for K-ras, cyclin D1, and p53 (8,13).  Several of these same gene mutations are 
also observed in cases of small intestine cancer (14). 
Differences in cancer susceptibility between the small and large intestine.   
Despite anatomical similarities between the small and large intestine as well as the 
similar genetic alterations that occur during carcinogenesis, the small intestine remains 
highly resistant to tumorigenesis.  Over the past several decades, a number of 
environmental and intrinsic differences between the small and large intestine have been 
proposed and evaluated in an attempt to explain the difference in cancer susceptibility 
between these two tissues.  The fluid nature of the luminal contents in the small intestine 
may infer protection as oral carcinogens would be more dilute.  Furthermore, the rapid 
transit through the small intestine may also minimize exposure time (3).  The 
environment of the small intestine is also relatively sterile compared to the large 
intestine.  It is well-documented that bacteria are required for the activation of 
methylazoxymethanol (MAM) an experimental, colon-specific carcinogen and the 
colonic microflora have also been implicated in the formation of tumor promoting 
secondary bile acids (3).  However, the relevance of environmental differences between 
the small and large intestine was seriously questioned following a study by Gennaro et 
al. (15) in 1973.  In this study, segments of the small intestine were transposed into the 
colon and segments of the colon were transposed into the small intestine in rats.  
Following treatment with a chemical carcinogen, tumors were found throughout the 
colon but not within the transposed small intestine segment.  Furthermore, very few 
tumors were found in the small intestine with the exception of the transposed segment of 
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colon which contained a number of adenocarcinomas.  This investigation suggested that 
something intrinsic to the small intestine tissue was responsible for its apparent tumor 
resistance and prompted a more thorough examination of the inherent differences 
between the small and large intestine tissue.   
Cell turnover, or the rate of cell proliferation and cell death, is much more rapid 
in the small intestine and proved a reasonable argument for tumor resistance.  However, 
in the colon, it is widely accepted that increased rates of cell proliferation are a risk 
factor for carcinogenesis (16,17).  The small intestine also contains benzpyrene 
hydrolase, a detoxifying enzyme absent in the colon that is responsible for degradation 
of the potent carcinogen, benzpyrene.  While other detoxification enzymes may exist, 
none have been well characterized (14).  One highly plausible intrinsic difference, but in 
need of further investigation, is the presence of a strong, localized immune system in the 
small intestine.  High levels of immunoglobulin A (IgA), an important defense against 
viruses, are found in the small intestine and patients with a deficiency in this 
immunoglobulin display an increased risk of cancer (14).  Another major finding by 
Potten and colleagues (17,18), is the evidence that apoptosis, in response to a carcinogen 
or cytotoxic insult in the small intestine of mice, is targeted to the stem cell population.  
Stem cells are a group of progenitor cells located near the base of the crypt which are 
responsible for maintaining the population of epithelial cells.  If stem cells become 
damaged or suffer mutations and continue to proliferate, the potential exists to generate a 
large number of epithelial cells with the same mutations.  In the colon, apoptosis was not 
found to be targeted to the stem cell population (17,19).  Thus the small intestine may be 
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more protected against cancer by targeted elimination of damaged and potentially 
mutated stem cells.   
Chemical and radiation carcinogenesis.  To study colon carcinogenesis in 
animal models requires the use of chemical carcinogens as most animals (with the 
exception of those with engineered genetic modifications) do not spontaneously develop 
colon cancer within their normal life cycle.  Mice and rats remain the species of choice 
in dietary studies on colon cancer prevention and the alkylating chemical carcinogens, 
1,2-dimethylhydrazine (DMH), methylazoxymethanol acetate (MAM) and 
azoxymethane (AOM) are the most frequently used as they specifically target the colon.  
These carcinogens are metabolically related, with DMH being converted to AOM in the 
liver followed by conversion to MAM.  The continued metabolism of MAM leads to the 
ultimate formation of a methylcarbonium ion, the biologically active carcinogen 
responsible for the alkylation of DNA (20). 
Enhancement of colonic epithelial cell proliferation is characteristic of 
administration of this family of chemical carcinogens and a hallmark of carcinogenesis.  
Hyperproliferation leads to aberrations in crypt formation that are often considered pre-
neoplastic lesions and are similar to changes in the crypt architecture of human colon 
tissue adjacent to colon tumors (11).  Of critical importance in the use of this animal 
model is the response to dietary changes.  This chemically-induced carcinogenesis 
model is responsive to dietary changes, especially changes in fat, which corresponds to 
epidemiological studies showing an increase in tumor formation with increased dietary 
fat intake (21). 
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In addition to chemical carcinogens, ionizing radiation has been shown, in as 
early as 1902, to induce cancer.  Since that time, ionizing radiation has gained the 
reputation of a “universal carcinogen,” in that it can cause cancer in most tissues, in most 
species of animal, at any stage of the life cycle (10).  As compared to chemical agents, 
radiation is generally considered a weak carcinogen, but this is dependent on the dose 
received and duration of exposure.  Additionally, radiation is able to avoid most of the 
cellular barriers presented to chemical carcinogens and can directly penetrate cells to 
damage DNA (10).  The type of DNA damage caused by radiation can be quite diverse 
and differ from that caused by chemical agents.  It is generally accepted that the primary 
DNA lesion responsible for the mutagenic results of ionizing radiation is the double 
strand break (DSB).  Repair of this form of DNA damage is highly error-prone and thus 
responsible for large-scale chromosomal abnormalities and multiple genetic mutations 
(22).  The DSB is a direct result of the interaction of radiation with DNA.  However, 
radiation can also indirectly cause DNA damage by the generation of oxidative stress 
within a cell, leading to oxidation of DNA bases.  This type of DNA damage is not as 
immediate as a DSB, but it still may play an important role in carcinogenesis as the 
oxidative stress resulting from radiation has been shown to continue into later 
generations of daughter cells (23,24).  
Environmental Factors in Colon Cancer 
Epidemiological investigations.  Although the role of genetic factors in colon 
cancer is well established, epidemiological studies of diverse and migrant populations 
suggest that environmental factors, especially dietary patterns, play an equally critical 
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role (2).  Studies among the Japanese in the 1960s prompted Wynder et al. (25) to 
propose a strong association between fat intake and colon cancer.  Just a few years later, 
Dr. Denis Burkitt, a medical missionary in Africa, reported fewer deaths from colon 
cancer in native Africans consuming a high-fiber, low-fat diet (26).  Since these 
important observations, dietary fat and fiber have emerged as two of the most important 
and widely investigated dietary factors related to colon carcinogenesis.  While early 
epidemiological studies focused primarily on the amount of fat and fiber in the diet, 
more recent investigations have determined that not only the amount, but the type of fat 
and fiber in the diet may affect colon cancer risk. 
Dietary fat and colon cancer.  Dietary fat has been considered by many experts 
to be the most important nutritional modulator of colon cancer risk (27,28).  This is not 
surprising considering that the majority of epidemiological and case-control studies over 
the past few decades have shown a positive association between high-fat diets and risk 
of colon cancer (29-34).  In addition to the amount of fat in the diet, the type of fat also 
has been shown to affect colon cancer risk, with the greatest risk found among 
individuals with elevated intakes of saturated or animal fat (31,32,34,35).  Interestingly, 
the only beneficial effect of a high-fat diet was seen when the diet was rich in 
polyunsaturated fatty acids (PUFAs), particularly those found in fish oil (35,36).  
Similarly, Blot et al. (37) observed that diets rich in marine animals and fish, common 
among Alaska natives, was associated with a decreased risk of colon cancer as compared 
to other North Americans. 
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Animal studies have further supported the link between the type of dietary fat 
and colon cancer risk as well as suggesting possible mechanisms of action (38-44).  
Reddy et al. (42) found that rats fed diets containing high levels of fish oil had fewer 
experimentally induced colon tumors than rats fed diets high in corn or safflower oil.  
Another investigation found that a high-fat fish oil diet was more protective against 
tumor formation than a low-fat corn oil diet (43).  Fish oil and corn oil differ in their 
fatty acid composition, with fish oil being rich in the omega-3 fatty acids 
eicosapetaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), and 
corn oil being rich in omega-6 fatty acids such as linoleic acid (LA, 18:2n-6).  It is 
suggested that this unique composition of fatty acids determines the ability of these 
dietary lipids to differentially influence colon tumorigenesis. 
The wealth of research on the role of fatty acids in colon cancer focuses on their 
ability to modulate phospholipid turnover and composition and prostaglandin synthesis 
(45,46).  The omega-3 fatty acids EPA and DHA, found in fish oil, have been shown to 
compete with LA (and its derivative arachidonic acid, AA) for incorporation into 
phospholipids.  Phospholipids play a critical role in signaling pathways for cell 
proliferation and differentiation, thus alteration of their fatty acid content may influence 
their signaling ability (47,48).  EPA also competes with AA for conversion to 
prostaglandins by cyclooxygenase enzymes.  Cyclooxygenase-2 (COX-2), an inducible 
form, is up-regulated in colon cancer but is suppressed by fish oil diets (46).  This is a 
particularly promising and potent mechanism of fish oil as pharmacological COX-2 
inhibitors have shown considerable effectiveness in colon cancer prevention(46).    
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Omega-3 fatty acids found in fish oil may also protect against colon cancer by 
mechanisms other than their ability to compete with omega-6 fatty acids.  Chang et al. 
(49) showed that the ability of fish oil to protect against colon tumorigenesis was due to 
an increase in apoptosis.  However, the mechanism by which this diet induces apoptosis 
is not yet clear.  A recent investigation suggests that the highly unsaturated fatty acids in 
fish oil are readily incorporated into the mitochondrial membrane making it more 
susceptible to reactive oxygen species (ROS) generation and propagation which may 
initiate apoptosis (50). 
Dietary fiber and colon cancer.  Along with dietary fat, dietary fiber has 
received considerable attention for its potential to protect against colon cancer.  
Population based studies have found strong associations between fiber intake and 
reduced risk of colon cancer (26,51,52).   Prospective studies have not been as 
conclusive (34,53,54), although one of the most recent and well-designed investigations, 
the European Prospective Investigation into Cancer and Nutrition (EPIC) study, found 
that doubling fiber intake from foods may decrease the risk of colon cancer by 40% (55).  
While many case-control studies have found a protective effect of fiber, specifically the 
fiber found in fruits and vegetables, several have also found no association between 
intake of fiber and colon cancer (27).  The inconsistency of these studies has created a 
fiber controversy among experts and left the public confused.  Some of the discrepancies 
may be attributed to the type of fiber investigated, the stage at which intervention began 
and the interaction of fiber with other dietary components. 
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Dietary fiber has only recently been defined as “non-digestible carbohydrates and 
lignan that are intrinsic and intact in plants (56).”  Within this broad definition exists 
many different fibers which can be classified primarily by their fermentability.  
Fermentation is accomplished by the microflora of the colon, with the major products 
being H2, methane, CO2, and short chain fatty acids.  The fermentability of a fiber is 
likely the determining characteristic in its ability to protect against colon cancer (57), but 
this remains the subject of much debate since highly fermentable and poorly fermentable 
fibers both show chemoprotective effects.  Poorly fermentable fibers, such as cellulose 
and wheat bran, have been considered protective due to their ability to dilute possible 
carcinogens and accelerate transit time.  However, the fermentation products of fiber, 
specifically the short chain fatty acid, butyrate, have also been shown to possess 
chemopreventive qualities (57,58).  Butyrate’s primary protective effects include 
inhibition of cell proliferation and enhancement of cell differentiation and apoptosis in 
colon cancer cell lines (59,60).  Yet controversy remains regarding the efficacy of 
butyrate as a chemopreventive agent due to the lack of supporting data in vivo.  The few 
studies which have examined the effects of butyrate in the colon of experimental animals 
have not found a protective effect of butyrate on aberrant crypt formation or colon tumor 
development (61-63). 
Interaction of dietary fat and fiber.  While a number of potential explanations 
exist for the differential effects of dietary fiber and butyrate on colon cancer 
development, of particular interest is the interaction of fiber with other dietary 
components, such as fat.  A study by Chang et al. (49) demonstrated that the fermentable 
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fiber pectin is protective against colon tumorigenesis when combined with fish oil in the 
diet.  Thus, it appears that the fatty acid composition of the diet may alter the action of 
the fiber.  Recent studies continue to support this finding and have suggested the 
mechanism of action of this dietary combination may be enhancement of apoptosis 
(50,64). 
Oxidative Stress and Carcinogenesis 
Reactive oxygen species in the carcinogenic process.  Reactive oxygen species 
(ROS) have been shown to play somewhat paradoxical roles in the carcinogenic process, 
serving as both promoters and protectors against tumorigenesis.  ROS are cellular 
oxidants which include free radicals such as superoxide (O2⋅-), hydroxyl (OH⋅) and 
peroxyl (RO2⋅), as well as non-radical species such as hydrogen peroxide (H2O2).  These 
oxidizing species are a common by-product of several cellular processes including 
aerobic metabolism, fatty acid oxidation, cytochrome P450 activity, and the respiratory 
burst of immune cells (9).  There also are a number of exogenous sources of ROS, 
especially in the colon, including oxidized food particles, toxins and transition metals 
(65).  Radiation exposure can also lead to the formation of cellular ROS (24,66). 
ROS have been implicated in the carcinogenic process by their ability to oxidize 
and damage DNA and other macromolecules, including proteins and lipids (9,67).  
Damage to DNA can lead to mutations in the genome, while oxidation of proteins and 
lipids may cause functional alterations or modifications in cell signaling that trigger 
undesirable responses such as enhanced proliferation (9).  Lipid oxidation results in the 
formation of lipid peroxides which can further oxidize other macromolecules including 
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other fatty acids within membranes (68).  Polyunsaturated fatty acids are frequent targets 
of ROS and their susceptibility to oxidation increases with their degree of unsaturation 
(69).  Thus long chain PUFAs, such as EPA and DHA, with five to six double bonds are 
at greater risk of oxidation than PUFAs with fewer double bonds, such as linoleic acid.  
Lipid peroxidation is of particular concern within cellular membranes when peroxide 
propagation is not terminated by antioxidants, which can result in large-scale damage to 
the membrane.   
Despite the apparent harm that may be caused by ROS, these oxidants also play a 
critical role in a number of important biological processes.  As mentioned previously, the 
respiratory burst of immune cells, particularly phagocytes, generates a large amount of 
ROS.  The ROS generated enable the immune cell to destroy engulfed bacteria as well as 
potential cancer cells (70).  In addition, cytochrome P450 activity is necessary for the 
detoxification of toxic substances and drugs for removal from the body.  Much of this 
detoxification process requires the generation of ROS.  Finally, accumulating evidence is 
revealing ROS to be critical initiators and mediators of apoptosis during carcinogenesis 
(69-74).  Even lipid peroxides have been shown to promote apoptosis (75).  Thus ROS, 
while generally perceived as harmful and potentially carcinogenic by their ability to 
damage macromolecules, may actually be beneficial in their ability to trigger apoptosis 
in potential cancer cells. 
As ROS are short-lived molecules and can only be measured in living cells, 
currently the most suitable method of detection is fluorescence microscopy.  Fluorescent 
dyes can be taken up by live cells and are able to emit fluorescence upon oxidation 
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which can then be monitored using digital microscopy.  There are a number of vital dyes 
available, some specific for the detection of a particular species, however 
dichlorofluorescein diacetate (DCFDA) and its derivatives are frequently used because 
of their ability to detect a variety of ROS.  The chloromethyl derivative of DCFDA 
(CM-H2DCFDA) shows exceptional retention in live cells due to the reaction of thiols 
with the chloromethyl group which “traps” the dichlorofluorescein in the cell.  Oxidation 
by ROS yields a fluorescent dichlorofluorescein which is detectible and measurable 
using digital fluorescence microscopy. 
Role of oxidative DNA damage in carcinogenesis.  It is proposed that the 
primary mutagenic potential of ROS is their ability to damage DNA.  The most common 
form of ROS-induced DNA damage is oxidation of nucleotide bases, which can lead to a 
number of alterations in DNA from gross chromosomal rearrangements to specific point 
mutations (9).  These mutations can result in activation of an oncogene or inactivation of 
a tumor suppressor gene, both of which are characteristic of cancer development. 
Although a number of oxidative DNA adducts have been identified, the one most 
frequently linked to genetic mutations is 8-hydroxy-2’-deoxyguanosine (8OHdG).  This 
DNA lesion is generated by the attack of a hydroxyl radical on a guanosine nucleotide 
which alters its hydrogen binding specificity such that the modified base preferentially 
binds with adenine (A) instead of cytosine (C) during DNA replication.  The cytosine 
will then bind with thymidine (T) in the next replication cycle, achieving a complete 
guanosine (G) to thymidine transversion (9).    The oxidation of guanosine by ROS and 
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the resulting transversion has been suggested to be the point of mutation for several 
genes related to colon cancer development, including K-ras and p53 (9). 
Due to the classification of 8OHdG as a major pre-mutagenic lesion, it is 
frequently utilized as a biomarker of oxidative DNA damage (9,76,77).  However, 
accurate measurement of 8OHdG has posed many difficulties due to the creation of 
artifacts during the DNA isolation process.  High pressure liquid chromatography has 
been the most widely used technique for detection of 8OHdG adducts.  However, there 
is often large variability among similar experiments and it is suggested that this 
variability is due to the generation of artifactual adducts (76).  Thus, newer technologies 
were developed in an attempt to more accurately determine cellular levels of 8OHdG.  
Two of these technologies examine 8OHdG levels in intact cells or nuclei, thereby 
eliminating the need to isolate DNA and minimizing the generation of artifactual 
adducts. 
The single cell gel electrophoresis or comet assay has been frequently used to 
determine levels of DNA damage (primarily single and double strand breaks) within an 
individual cell (76,78,79).  The procedure involves isolation of intact nuclei from single 
cells followed by alkaline unwinding of the DNA.  Subsequent exposure of the nuclei to 
electrophoresis will result in the movement of fragmented DNA, indicative of damage, 
to form a comet-like structure that is visible under the microscope when the DNA is 
stained.  Collins et al. (80) proposed an additional enzyme digestion step within the 
comet assay.  The enzyme utilized was E. coli formamido pyrimidine glycosylase (fpg), 
which induces single strand breaks in DNA at the location of 8OHdG adducts.  Addition 
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of this enzyme to the comet assay increased the sensitivity of the assay for oxidative 
DNA damage as well as the specificity for the potentially mutagenic adduct, 8OHdG.  
This procedure, now termed the FLARE (fragment length analysis using repair enzymes) 
assay, has be used by several others (78,81-84), although debate has continued as to the 
appropriate method of quantitiation by image analysis.  While various quantitative and 
semi-quantitative methods, such as visual scoring, % DNA in the tail, and migration 
distance have been used, the method regarded as the best index of damage is the relative 
tail moment (85).  This measurement has gained respect due to its consideration of the 
total amount of DNA present within the cell which can differ based upon the stage of the 
cell cycle.  The relative tail moment evaluates the amount of DNA in the tail relative to 
the amount of DNA remaining in the nuclei (or head of the comet), unlike other methods 
which only examine the DNA contained in the tail. 
An alternative method for determining 8OHdG within intact cells is by 
immunohistochemistry using an antibody specific for the 8OHdG adduct.  Toyokuni et 
al. (86,87) have developed a monoclonal antibody with very low cross-reactivity to other 
oxidized bases, a concern with previously developed 8OHdG antibodies.  Similar to the 
FLARE assay, this method also eliminates the need for DNA isolation, thereby 
preventing the possible creation of artifactual adducts.  However, an additional 
advantage of this procedure is the ability to visualize cellular 8OHdG adduct staining 
while maintaining the crypt architecture of the colon. 
Role of antioxidant defenses in carcinogenesis.  To protect against the constant 
generation of ROS, cells posses a number of antioxidant defense mechanisms.  These 
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include non-enzymatic scavengers such as glutathione, uric acid, ascorbic acid and α-
tocopherol, as well as the enzymes superoxide dismutase (SOD), catalase (CAT), and 
glutathione peroxidase (GPx).  Additionally, proteins such as transferrin, metallothionein 
and ceruloplasmin may act indirectly as antioxidants by sequestering transition metals 
responsible for the generation of hydroxyl radicals (70,88).  These antioxidant defenses 
do not completely remove all ROS from the cell, indicating that ROS may play an 
important role in cellular functions and that antioxidants exist primarily to maintain a 
steady state of ROS (70).  In the event that ROS greatly exceed the antioxidant 
capabilities of the cell, either by increased generation of ROS or decreased capability of 
antioxidant defenses, a condition termed oxidative stress results (89).  Oxidative stress 
can cause a variety of cellular responses including changes in gene expression, 
stimulation of proliferation, growth-arrest and apoptosis.  Another possible consequence 
of oxidative stress is an increase in DNA damage. 
As oxidative damage to DNA can lead to mutagenesis, antioxidants can play a 
critical role in the prevention of mutations that may lead to cancer.  In support of this 
claim are epidemiological findings that increased intake of fruits and vegetables (rich in 
antioxidants) is associated with a decreased risk of certain cancers (9,90).  Additionally, 
high intake of certain antioxidant vitamins, such as vitamin E, has been shown to reduce 
the risk of colon cancer (91).  However, the chemoprotective effect of fruits and 
vegetables has not been conclusively linked to their antioxidant content or their ability to 
prevent DNA damage and mutation.  In fact, it has been suggested that the anti-cancer 
effects of fruits and vegetables may also be attributed to other protective substances such 
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as fibers and phytates or the finding that most diets high in fruits and vegetables are also 
low in fat which has been closely linked to cancer incidence (9). 
While antioxidants are generally perceived as beneficial by their ability to 
quench ROS, they have not always proven to be protective in chronic disease states, 
especially cancer.  Two of the most well known trials to find an adverse effect of 
antioxidant supplementation are the Alpha-Tocopherol, Beta-Carotene Cancer 
Prevention (ATBC) trial and the Carotene and Retinol Efficacy Trial (CARET).  Both of 
these studies found an increased incidence of lung cancer and mortality in smokers 
supplemented with the antioxidant, β-carotene, compared to their non-supplemented, 
smoking counterparts (92,93).  In fact, the CARET trial was terminated 21 months 
prematurely due to these findings.  Other clinical investigations into antioxidant enzyme 
defenses have shown that elevation of SOD activity in human colon carcinomas is 
associated with a poor 5 y survival rate (94).  Furthermore, studies in cell lines and 
animals have shown overexpression of antioxidant enzymes promotes tumor survival 
(95), while depletion of antioxidants prevents tumor growth and enhances tumor cell 
death (96).  In agreement with these findings is a recent study that found high doses of 
β-carotene to enhance aberrant crypt formation in an AOM model of colon 
carcinogenesis in rats (97).   The common hypothesis that many of these studies propose 
as to the harmful effects of antioxidants is their ability of quench ROS that may be 
necessary for stress-mediated pathways such as apoptosis.  
The role of ROS in apoptosis.  There have been a number of ROS-mediated 
pathways identified which influence cell growth and survival (98), but one of the most 
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intriguing and widely investigated is apoptosis.  Apoptosis is a programmed mechanism 
of cell death which selectively eliminates damaged cells that have the potential to form 
cancer cells.  The biochemical pathways characteristic of apoptosis have been well 
characterized and are highly conserved among different species (74).  These pathways 
include disruption of the mitochondrial membrane, activation of caspases and changes in 
gene expression, each of which are influenced by ROS. 
Alterations in the mitochondria occur early in the apoptotic sequence, with the 
most obvious change being loss of mitochondrial membrane potential (Ψm).  While the 
loss of membrane potential alone can induce oxidative stress, ROS can also oxidize the 
mitochondrial membrane lipids, damaging the membrane and leading to altered Ψm (74).  
The greater content of long chain PUFAs in the membrane, the more susceptible the 
mitochondria is to damage by ROS (50).  Severe oxidative stress can lead to opening of 
the permeability transition pore, which in addition to disturbing the membrane potential, 
also releases large molecules into the cytosol.  Several of these molecules, such as 
cytochrome c and apoptosis-inducing factor, continue the downstream events of 
apoptosis (99). 
Cytochrome c has been shown to activate cytosolic caspases, enzymes that are 
responsible for continuing the process of apoptosis by degrading proteins critical to cell 
survival.  Caspases are cysteine proteases and thus are sensitive to the oxidative status of 
the cell.  In fact, investigations show that a redox shift in a cell towards a more oxidized 
environment is a necessary occurrence prior to caspase activation (99,100).  
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Furthermore, in cell culture experiments, the addition of antioxidants blocked apoptosis 
in a similar fashion to caspase inhibitors (101,102). 
Several investigations have suggested that ROS per se are not the actual initiators 
of apoptosis, but rather an oxidative shift in the cellular environment which generates an 
apoptotic signal (75,103-105).  Modulations in the cellular redox environment can be 
determined by changes in the ratio of glutathione (GSH) to its oxidized counterpart, 
glutathione disulfide (GSSG).  The GSH redox cycle is highly sensitive to changes in the 
oxidative environment due to the rapid formation of GSSG from 2 molecules of GSH in 
the presence of ROS, in combination with the rapid enzymatic recycling back to GSH.  
In fact, Wang et al. (75) was able to detect significant changes in GSH/GSSG within 15 
min of an oxidative challenge which correlated with later activation of caspases.  
Another investigation determined that oxidation of GSH precedes DNA fragmentation, a 
hallmark of apoptosis (105).  Therefore, using the GSH redox cycle to measure changes 
in the oxidative environment may reveal greater insight into the mechanisms of ROS-
induced apoptosis than the measurement of absolute levels of ROS. 
Summary and Purpose 
For several decades the variation in cancer susceptibility between the small 
intestine and colon has remained unclear.  Environmental and intrinsic differences 
between these two tissues have been investigated, but still provide only an incomplete 
explanation.  One inherent difference which may play a critical role in the tumorigenic 
process that has not been well investigated is the oxidative environment of these two 
tissues.  The cellular redox environment is determined by the balance of ROS generation 
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and antioxidant defenses.  Differences in the steady state redox balance may alter the 
levels of oxidative DNA damage as well as the ability of the tissue to respond to 
additional oxidative stress.  These differences may contribute to the variation in cancer 
susceptibility at these two intestinal sites. 
Colon cancer is also one of the most preventable cancers by dietary intervention 
and fat and fiber are two of the most widely investigated dietary components in colon 
cancer prevention.  There is substantial evidence that diets rich in n-3 PUFAs, such as 
those found in fish oil (EPA and DHA) protect against colon carcinogenesis.  However, 
the chemopreventive abilities of fiber, fermentable and non-fermentable, have been the 
subject of much debate and have shown varied results in intervention trials and 
epidemiological studies.  It has been proposed that the inconsistent effect seen with fiber 
may be somewhat attributable to the influence of fat in the diet.  Specifically, our 
laboratory has shown that the fermentable fiber, pectin, in combination with fish oil has 
a synergistic, protective effect on multiple stages of colon cancer primarily through the 
enhancement of apoptosis, a form of programmed cell death (49,64).  Evidence suggests 
these dietary constituents may enhance apoptosis through alterations of the cellular 
redox environment.  Dietary fat and to a lesser extent dietary fiber, have been shown to 
alter cellular ROS and lipid peroxidation, while other studies have shown its impact on 
antioxidant enzyme expression and activity (106-109). 
This study will evaluate the differences in ROS generation, response to 
exogenous ROS, antioxidant defenses and oxidative DNA adducts in the small intestine 
and colon in an effort to explain, in part, the dramatic difference in cancer occurrence at 
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these two similar organ sites.  Additionally, this investigation will evaluate the ability of 
dietary lipid and fiber to alter the oxidative status of colonocytes in a manner to infer 
protection against colon carcinogenesis. 
Hypotheses   
1)  The colon will have a more prooxidant environment as compared to the small 
intestine and therefore respond unfavorably to additional oxidative stress. 
2) The colonic redox environment will be altered by dietary fat and fiber such that fish 
oil and pectin will be protective prior to and during the initiation stage of radiation 
enhanced, chemically-induced colon cancer by minimizing oxidative DNA damage and 
promoting ROS-induced apoptosis. 
Specific Aims 
1)  Determine the steady-state levels of ROS, antioxidant enzyme activity, and oxidative 
DNA damage in the small intestine and colon of rats. 
2)  Determine changes in ROS and oxidative DNA damage in the small intestine and 
colon of rats when exposed to an exogenous source of ROS. 
3)  Determine the effect of fat and fiber on ROS generation, oxidative DNA damage, 
antioxidant enzyme activity and apoptosis in the colon prior to exposure to carcinogen or 
ionizing radiation. 
4)  Determine the effect of fat and fiber on GSH/GSSG, oxidative DNA damage and 
apoptosis in colonocytes of rats exposed to AOM and ionizing radiation. 
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CHAPTER II 
PRO-OXIDANT ENVIRONMENT OF THE COLON COMPARED 
TO THE SMALL INTESTINE MAY CONTRIBUTE TO GREATER 
CANCER SUSCEPTIBILITY*
 
It is predicted that the cases of colorectal cancer this year will outnumber small 
intestine cancer cases 28 to 1 (110), despite the fact that the small intestine has over 3 
times the surface area of the colon.  While the variation in cancer occurrence between 
these two intestinal sites is not completely understood, environmental differences such 
as the presence or absence of bacterial microflora, and intrinsic differences such as the 
rate of cell turnover have been examined (3,17).  Yet, these differences provide an 
incomplete explanation for the variation in cancer susceptibility.  For example, cell 
turnover involves the proliferation of cells as well as cell death.  The more rapid rate of 
cell death in the small intestine as compared to the colon should infer protection against 
cancer development as potentially tumorigenic cells could be quickly eliminated.  
However, the small intestine also has a greater rate of cell proliferation which may 
promote tumorigenesis as transformed cells must propagate for tumors to develop (16).   
                                                 
* Reprinted from Cancer Letters, v. 208(2), Sanders, L. M., Henderson, C. E., Hong, M. Y., Barhoumi, R., 
Burghardt, R. C., Carroll, R. J., Turner, N. D., Chapkin, R. S., & Lupton, J. R.  Pro-oxidant environment 
of the colon compared to the small intestine may contribute to greater cancer susceptibility. pp. 155-161, 
2004, with permission from Elsevier. 
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One inherent difference which may play a critical role in the tumorigenic process that 
has not been well investigated is the oxidative environment of these two tissues. 
Damage to DNA from ROS is a consequence of oxidative stress, and several 
oxidative DNA adducts, including 8-hydroxy-deoxyguanosine (8OHdG), have been 
implicated in the tumorigenic process (9,68,76,111).  Oxidative stress exists when pro-
oxidants such as ROS exceed antioxidant capabilities.  This environment can result from 
increased generation of ROS as well as impaired removal of ROS by antioxidant 
defenses such as superoxide dismutase (SOD), catalase (CAT), and glutathione 
peroxidase (GPx) enzyme systems (Figure 1).  Differences in ROS generation or 
antioxidant enzyme activities between the small intestine and colon may alter the levels 
of oxidative DNA damage, thus contributing to the variation in cancer susceptibility at 
these two intestinal sites. 
The current study evaluated the differences in ROS generation, antioxidant 
enzyme activities and oxidative DNA adducts in the small intestine and colon in an 
effort to explain, in part, the dramatic difference in cancer occurrence at these two 
similar organ sites. 
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FIGURE 1  Cellular antioxidant enzyme defenses against reactive oxygen species.  Superoxide radicals 
(O2•-) can be generated from O2 via cellular oxidases or mitochondrial electron transport.  Superoxide 
dismutase (SOD) converts superoxide radicals to the non-radical reactive species, H2O2.  H2O2 can be 
removed enzymatically by glutathione peroxidase (GPx) or catalase (CAT) to form water and/or O2.  
Alternatively, H2O2 can react with iron (Fe) or copper (Cu) via a Fenton reaction to form hydroxyl radicals 
(OH•) that can directly damage DNA.  The balance of the activity of these enzymes in the generation and 
removal of H2O2 is crucial in maintaining the oxidative status of the cell. 
 
 
Materials and Methods 
Animals and diets.  Animal protocols were approved by the University Animal 
Care Committee of Texas A&M University and conformed to the National Institutes of 
Health guidelines (NRC 1985).  Sixty male weanling (28-d old) and 40 9-mo old 
Sprague-Dawley rats (Harlan Sprague Dawley, Houston, Texas) were housed 
individually in raised wire cages and maintained in a temperature- and humidity-
controlled animal facility with a daily photoperiod of 12 h light and 12 h dark.  The rats 
were stratified by body weight and assigned to one of four defined diets (25 rats/diet), 
which were consumed for 2 wk.   
Cell isolation.  Enterocytes and colonocytes were isolated based on a procedure 
by Zoran et al. (112).  After rats were euthanized, the colon and small intestine were 
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removed and flushed with warm Ca2+- and Mg2+-free PBS (GibcoBRL, Grand Island, 
NY).  The first 10 cm of small intestine and last half of the colon were taken as 
duodenum and distal colon, respectively.  Each segment was cut longitudinally to expose 
the lumen and placed in warm (37°C) Ca and Mg free Hank's Balanced Salt Solution 
(HBSS), 30 mM EDTA, 5 mM dithiothreitol (DTT), 0.1% fatty acid free BSA, 1 mM 
glutamine and 1 mM butyrate (pH 7.4).  Following a 15 min shaking incubation, the 
mucosal side of each segment was gently scraped with a rubber policeman to remove 
surface epithelial cells as well as intact intestinal crypts (113).  Removal of crypts and 
surface cells was confirmed by histological examination of remaining intestinal tissue 
following the scraping procedure.  The isolated epithelial cells were washed in warm 
HBSS containing Ca2+ and Mg2+, 0.1% BSA, 1 mM glutamine, and 1 mM butyrate.  
Two aliquots of cells from the duodenum and distal colon were taken for antioxidant 
enzyme analysis and Fragment Length Analysis using Repair Enzymes (FLARE) 
analysis (114).  The remaining cell suspensions were used for ROS analysis as described 
below. 
Detection of reactive oxygen species.  Isolated enterocytes and colonocytes 
(maintained at 37°C) were divided into two treatment groups, which received either an 
oxidative challenge of 50 µM H2O2 for 5 min or no treatment (basal).  This 
concentration of H2O2 was chosen as it was sufficient to create an oxidative stress 
without being toxic to the cells.  Exposure time was necessarily limited due to the short-
term viability of coloncytes and enterocytes ex vivo.  Samples were prepared in duplicate 
and incubated for 15 min with CM-H2DCFDA (Molecular Probes, Eugene, OR), a 
 29
fluorescence probe sensitive to such cellular oxidants as hydrogen peroxide (H2O2), 
hydroxyl radicals (OH•), and peroxyl radicals (OOH•).  This probe passively diffuses 
into cells and upon oxidation by ROS forms a fluorescent adduct which remains trapped 
in the cell.  Fluorescence was monitored on a Meridian Ultima confocal microscope 
(Meridian Instruments, Okemos, MI) with a 530 nm barrier filter and laser excitation at 
488 nm, as previously described (115).  Intensity of fluorescence is used as an indirect 
measure of prevalence of ROS.  Data for each sample were collected from 15 
fields/treatment/rat.  Viability of the cells used for analysis was determined after each 
treatment by staining with ethidium homodimer–1.  Mean viability was 81 ± 4.5%. 
Measurement of oxidative DNA damage using the FLARE assay.  FLARE kits 
were purchased from Trevigen (Gaithersburg, MD).  This assay is a modification of the 
single cell gel electrophoresis (comet) assay, which uses fpg to introduce DNA strand 
breaks at 8OHdG, a prevalent and potentially mutagenic oxidative adduct.  This process 
allows measurement of 8OHdG on a single cell level in intact nuclei thus reducing the 
confounding factor of artifactual adducts (114).  Isolated surface epithelial cells and 
crypts from the duodenum and distal colon were divided into two treatment groups 
receiving either an oxidative challenge of 50 µM H2O2 for 5 min or no treatment (basal).  
Intact crypts were broken into single cells by aspiration through 27 gauge needle and 
plated with agarose in duplicate on comet slides.  Slides were then exposed to a lysis 
buffer, followed by immersion in 1X FLARE buffer according to the kit protocol.  Slides 
were treated with fpg enzyme diluted 1:50 with reaction buffer and a control slide 
received reaction buffer without fpg enzyme.  Following treatment with alkali solution, 
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the slides were exposed to electrophoresis (1 V/cm, 20 min), immersed briefly in 70% 
ethanol and stored horizontally.  Nuclei were viewed by epifluorescence microscopy 
using SYBR green staining.  Quantitation of the relative tail moment (tail moment/(tail 
moment + head moment) x 100) (78) was measured using the Metamorph Imaging 
System (v.4.6r3, Universal Imaging Corp., Downington, PA) and a macro designed by 
Nikon.  One hundred randomly selected cells were analyzed per treatment group for 
each rat. 
Measurement of antioxidant enzyme activity.  Activities of CAT, GPx, and SOD 
in isolated enterocytes and colonocytes during basal condition (no H2O2 treatment) were 
measured spectrophotometrically using assay kits from Calbiochem (San Diego, CA).  
Cell lysates were prepared by homogenization of cells in 50 mM potassium phosphate 
buffer (250 mM sucrose/1 mM EDTA/1 mM DTT/0.1% Triton X-100) followed by 
centrifugation for 3 min at 10,000 x g.  Supernatant was used for enzyme assays 
following protocols provided in the kit.  Briefly, SOD activity was determined by 
measuring the rate of generation of a chromophore at 525 nm.   CAT activity was 
determined by measuring absorbance of quinoneimene dye at 520 nm.  GPx was 
determined indirectly by oxidation of NADPH to NADP+ measured at 340 nm.  (Due to 
use of cell lysates H2O2 was the preferred substrate over tert-butyl hydroperoxide as this 
compound is also a substrate for some glutathione transferases (116).  Sodium azide 
(NaN3) was used to inhibit catalase competition for H2O2.)  Samples were assayed in 
triplicate in 96 well microplates with standards provided in kits or purchased separately.  
Microplates were read on a Spectra Max 250 microtiter plate reader using SoftMax Pro 
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v.1.2 software (Molecular Devices, Sunnyvale, CA).  Activity was normalized to protein 
concentration as determined by Coomassie Blue assay kits (Pierce Biotechnologies, 
Rockford, IL). 
Statistical analysis.  Analysis of ROS, antioxidant enzyme activity and oxidative 
DNA damage data was performed by analysis of variance (ANOVA) using SAS 8.0 
(SAS Institute, Inc).  Results were considered significant at p<0.05.  The results 
presented here were not affected by the diet or age of the animal. 
 
Results 
Generation of reactive oxygen species.  The basal levels of ROS, as determined 
by indirect fluorescence microscopy with the probe CMH2DCFDA, in the epithelial cells 
of the colon were significantly greater than the ROS levels found in the small intestine 
(p<0.0001) (Figure 2).  When exposed to an oxidative challenge of 50 µM H2O2, the 
colon continued to maintain greater levels of ROS as compared to the small intestine 
(p<0.0001).  Both tissues experienced a significant increase in ROS over basal levels 
during oxidative stress (p<0.02). 
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FIGURE 2  Levels of ROS are greater in the colon than the small intestine.  Isolated epithelial cells from 
the intestine were analyzed for ROS by fluorescence microscopy.  Intensity of fluorescence was used as an 
indirect measurement of prevalence of ROS.  All samples were prepared in duplicate.  Data are means ± 
SEM from 80 rats with 15 readings/treatment.  * Represents mean significantly greater than the same 
measurement in the small intestine (p<0.0001).  † Represents mean significantly greater than the 
unstressed levels in the same tissue (p<0.02). 
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Oxidative DNA damage.  Levels of 8OHdG as measured by the FLARE assay 
were used as a marker of oxidative DNA damage.  During basal conditions (without H-
2O2 treatment), the level of oxidative DNA damage did not differ between the small 
intestine and colon (Figure 3).  However, in an oxidatively stressful environment, the 
difference in damage between the colon and small intestine was enhanced.  During 
exogenous stress with 50 µM H2O2, the colon exhibited significantly greater oxidative 
DNA damage compared to the small intestine (p<0.038).  Both tissues exhibited a 
significant increase in oxidative DNA damage over basal levels with the addition of an 
exogenous oxidant stress (p<0.0001). 
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Antioxidant enzyme activity.  Antioxidant enzyme activities for SOD, CAT and 
GPx were greater in the colon as compared to the small intestine (p<0.008, p<0.006, 
p<0.0001 respectively) (Figure 4).  CAT and SOD displayed 20-35% greater activity in 
the colon than the small intestine, while GPx activity was 72% greater in the colon. 
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FIGURE 3  During oxidative stress the colon exhibits significantly more oxidative DNA damage than the 
small intestine.  Isolated intestinal epithelial cells were analyzed for oxidative DNA damage with the 
FLARE assay with relative tail moment (RTM) as the quantitative measurement.  Experiments were 
conducted in duplicate.  Data are means ± SEM from 40 rats with 100 cells/tissue/rat analyzed.  * 
Represents mean significantly greater than the same measurement in the small intestine (p<0.038).  † 
Represents mean significantly greater than the unstressed levels in the same tissue (p<0.0001). 
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FIGURE 4  The activity of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase 
(GPx) was greater in the colon (C) than the small intestine (SI).  Isolated intestinal epithelial cells were 
analyzed for antioxidant enzyme activity by spectrophotometry.  Data are means ± SEM from 40 rats with 
3 readings/tissue.  * Represents mean significantly greater than the mean for the small intestine (p<0.008). 
 
 
Discussion 
Limited research is available on small intestine cancer due to the rarity of this 
disease.  However, there are abundant investigations into the etiology and cause of colon 
cancer, the second leading cause of cancer death in the US.  While these anatomical sites 
share structural and functional similarities, there also exist inherent differences which 
may contribute to the variation in cancer incidence.  In this investigation we propose that 
intrinsic differences in redox status and response to oxidative stress contribute to 
differences in cancer occurrence in the small intestine and colon. 
ROS are frequently implicated as key players in tumorigenesis primarily by their 
potentially mutagenic oxidation of DNA.  Our current data show the colon to have 
significantly greater basal levels of ROS than the small intestine, thereby creating an 
environment for more extensive oxidative DNA damage.  While many exogenous 
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sources of ROS in the intestine have been determined, endogenous sources have not 
been well investigated.  There is considerable evidence that a key producer of 
endogenous ROS is mitochondrial oxidative phosphorylation (71,117,118).  When this 
process operates inefficiently, superoxide radicals (O2•-) are produced that, if not 
quenched by antioxidant defenses, can lead to the formation of other damaging oxidants 
including hydrogen peroxide (H2O2) and hydroxyl radicals (OH•).  There is compelling 
evidence that oxidative metabolism in the colon is less efficient than in the small 
intestine.  Wu et al. (119) has shown the oxidation of butyrate (the primary energy 
substrate for colonocytes) yields 4.4 ATP/O2 while the oxidation of glutamine (the 
primary energy substrate for enterocytes) yields 5.3 ATP/O2.  This strongly suggests less 
efficient mitochondrial respiration exists in the colon, which could lead to increased 
production of ROS. 
Despite these elevations of endogenous ROS in the colon, levels of basal 8OHdG 
did not differ significantly between the two intestinal sites.  The resistance of the colon 
to oxidative DNA damage may be partially explained by enhanced protection against 
ROS via increases in the activity of antioxidant enzymes found at this site.  Indeed, 
overexpression of certain antioxidant enzymes has been shown to decrease urinary 
excretion of 8OHdG adducts (120) while elimination of specific antioxidant enzymes in 
knockout mice have resulted in enhanced cellular oxidative damage (121,122).  While 
our findings reveal antioxidant enzyme activity to be greater in the colon, other 
investigations have shown varied results. One report found no difference in GPx and 
SOD in the mucosa of rat small intestine and colon (123), while another investigation 
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found GPx activity to be slightly greater in the colon and rectum (124).  Yet another 
study found CAT and SOD to be greater in the small intestine than the colon (65).  
However, this study included in its measurements the submucosal layer of the intestine, 
which contains immune cells and possibly vascular endothelial and blood cells (125) 
rich in antioxidant enzymes.  The present study examined enzyme activity exclusively in 
the epithelial cells of the intestine, as these are the cells that undergo the process of 
malignant transformation as well as directly endure the exogenous stressors contained in 
the lumen. 
Other mechanisms besides antioxidant enzymes may also be at work to control 
oxidative DNA damage.  There are several DNA repair enzymes responsible for the 
removal of oxidative DNA adducts, including the excision repair enzyme oxoguanine 
glycosylase (OGG-1), specific for 8OHdG repair in eukaryotes.  However, the 
contribution of these repair enzymes in situations of elevated ROS may be minimal 
considering that even in basal conditions, the amount of DNA damage exceeds the repair 
capacity of these enzymes (126).  While comparisons of repair enzymes in the small 
intestine and colon has not been well characterized, findings in our laboratory indicate 
expression of the repair enzyme OGG-1 in the colon is not greater than in the small 
intestine despite enhanced generation of ROS in the colon (114).  Therefore, differences 
in DNA repair may not completely explain the resistance of the colon to oxidative DNA 
damage in the presence of elevated ROS.  
It is demonstrated here that while antioxidant enzyme activity is elevated in the 
colon, there is no significant enhancement of protection against oxidative DNA damage 
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when compared with the small intestine.  Furthermore, basal ROS levels continue to be 
elevated despite enhanced enzyme activity.  This suggests that under basal conditions in 
the colon, antioxidant enzymes are fully functional, which appears only sufficient to 
maintain, not reduce, oxidative DNA damage in the presence of elevated ROS.  As a 
result, there exists a rather precarious pro-oxidant basal environment in the colon that 
when challenged with an exogenous oxidant, predisposes the colonocytes for more 
severe oxidative stress and increased oxidative DNA damage over the small intestine.  
This is evidenced by the dramatic rise in ROS and 8OHdG adducts in the colon 
following brief exposure to 50 µM H2O2.  Specifically, the colon experienced a 50% 
increase in ROS from the basal level and 8OHdG adducts increased by 43%.  Exposure 
of the small intestine to the same exogenous stress yielded only a 24% increase in ROS 
and subsequent 36% increase in oxidative DNA damage.     
The inefficiency of the colon in managing exogenous oxidative stress is critical 
as the colon experiences greater oxidant exposure compared to the small intestine.  
Prolonged transit time in the colon allows for longer exposure to oxidized food particles, 
toxins and redox active minerals.  In addition, bacterial microflora consistently generate 
reactive metabolites (127).  This poses a significant hazard to the colon since oxidative 
stress is involved in the development of inflammatory bowel diseases (128) and has been 
shown to induce malignant transformation (129,130).  The inability of the colon to 
manage oxidative stress especially in the presence of chronic oxidant exposure may 
partially explain the predisposition of this site for inflammatory bowel diseases and 
cancer over the small intestine. 
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Overall, these data indicate that the colon generates more endogenous ROS than 
the small intestine which persists despite enhanced antioxidant enzyme function.  This 
seemingly pro-oxidant environment of the colon may lead to this tissue's inability to 
handle oxidative stress as effectively as the small intestine.  As a result, oxidative DNA 
damage in the colon is greater than in the small intestine during times of exogenous 
oxidant stress.  As oxidative damage has been implicated in the carcinogenic process, 
these results may help to explain the difference in cancer incidence between the small 
intestine and colon.  However, further functional studies of biological endpoints, such as 
tumor formation, are necessary to establish a definitive link between altered oxidative 
status and cancer susceptibility.  This is the first study to report ROS and oxidative DNA 
damage differences in the small intestine and colon.  Continued investigation of the 
inherent differences in these two similar tissues and their relation to cancer susceptibility 
can contribute to the understanding of the pathogenesis and possibly the future 
prevention of colon cancer. 
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CHAPTER III 
AN INCREASE IN REACTIVE OXYGEN SPECIES BY DIETARY 
FISH OIL COUPLED WITH THE ATTENUATION OF 
ANTIOXIDANT ENZYME DEFENSES BY DIETARY PECTIN 
ENHANCES RAT COLONOCYTE APOPTOSIS*
 
Colorectal cancer is anticipated to be the third most frequently diagnosed cancer 
in the US this year and it is predicted that almost half of individuals diagnosed will die 
from the disease within 5 y (1).  Yet many of these cases could be prevented by 
appropriate diet and lifestyle modifications.  Dietary fat and fiber are two of the most 
widely investigated dietary components with respect to colon cancer prevention 
(27,131).  There is substantial evidence that diets rich in (n-3) polyunsaturated fatty 
acids (PUFAs), such as those found in fish oil (eicosapentaenoic acid and 
docosahexaenoic acid) protect against colon carcinogenesis (49,132), while diets rich in 
(n-6) PUFAs, such as those found in corn oil appear to promote cancer development in 
the colon.  However, the chemopreventive abilities of fiber, fermentable and non-
fermentable, have been the subject of much debate and have shown varied results in 
intervention trials and epidemiological studies (133,134).  Poorly fermented fibers, such 
as cellulose, have been considered protective in their ability to dilute putative 
                                                 
* Reprinted with permission from Sanders, L.M., Henderson, C. E., Hong, M.Y., Barhoumi, R., Burghardt, 
R. C., Wang, N., Spinka, C. M., Carroll, R. J., Turner, N. D., Chapkin, R. S. & Lupton, J. R. (2004) An 
increase in reactive oxygen species by dietary fish oil coupled to the attenuation of antioxidant defenses by 
dietary pectin enhances rat colonocyte apoptosis. Journal of Nutrition 134: 3233-3238. 
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carcinogens that may be present in the fecal stream.  Yet, the products of highly 
fermentable fibers (i.e., butyrate) have been shown, at least in vitro to possess 
chemopreventive qualities (58).  We propose that the inconsistent effect seen with fiber 
may be attributable to the composition of fat in the diet (57).  Specifically, we have 
shown that the fermentable fiber, pectin, in combination with fish oil has a protective 
effect in multiple stages of colon cancer (49,135).  
The protective effect of this diet has been shown to be primarily through 
enhancement of apoptosis, a form of programmed cell death (49,64).  However, the 
mechanism by which the fish oil and pectin diet induces apoptosis has not been clearly 
elucidated.  Recent evidence suggests an important mediator of apoptosis is reactive 
oxygen species (ROS) (reviewed in 69).  Considering the degree of unsaturation of (n-3) 
PUFAs in combination with the rapid colonocyte oxidation of butyrate, this protective 
diet may alter cellular ROS in a manner sufficient to induce apoptosis in the colonocyte.  
Yet ROS can also damage and potentially mutate DNA (76); therefore, cells employ 
several defenses against ROS including antioxidant enzymes such as superoxide 
dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT).  While these 
enzymes are key players in preventing cellular damage caused by endogenous ROS 
(88,136), overexpression or addition of these enzymes to tissue systems has been shown 
to enhance tumorigenesis and block the action of several chemotherapeutic drugs by 
suppressing ROS-induced apoptosis (95,137). The ability of diet to modulate antioxidant 
enzyme expression and activity has been documented (107,108).  However the ability of 
diet to simultaneously influence additional redox factors, such as ROS generation, in the 
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colon has not been characterized.  This investigation evaluates the ability of dietary lipid 
and fiber to alter the oxidative status of rat colonocytes, via ROS generation and 
modulation of antioxidant enzyme activity, thus creating an environment permissive for 
apoptosis. 
 
Materials and Methods 
Animals and diets.  Animal use was approved by the University Animal Care 
Committee of Texas A&M University and conforms to National Institutes of Health 
guidelines (NRC 1985).  Sixty male weanling (28-d old) Sprague-Dawley rats (Harlan 
Sprague Dawley, Houston, Texas) were housed individually in raised wire cages to 
diminish coprophagy and maintained in a temperature- and humidity-controlled animal 
facility with a daily photoperiod of 12 h light and 12 h dark.  The rats were stratified by 
body weight and assigned to one of four experimental diets (15 rats/diet) as previously 
described (138). Experimental diets were consumed for 2 wk.  This study represents a 2 
x 2 factorial design with two types of fat (corn oil or fish oil) and two types of fiber 
(cellulose or pectin).  Dietary composition included 15% dietary fat by weight (30% 
kcals from fat) and 6% dietary fiber by weight (equivalent to 30 g fiber/d in a human 
diet).  The fish oil diet contained 3.5 g of corn oil/100 g diet to prevent essential fatty 
acid deficiency(48). The types of fiber were chosen based on their fermentability with 
cellulose being poorly fermentable and pectin being highly fermentable (112).  Corn oil 
and fish oil were analyzed for peroxide value (3.3 mEq/kg corn oil, 3.4 mEq/kg fish oil), 
fatty acid composition and antioxidant composition.  To ensure equal antioxidant content 
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in all diets, fish oil was supplemented with α-tocopherol, γ-tocopherol and tert-butyl 
hydroquinone equal to the levels found in corn oil.  Food and water were freely 
available.  To minimize fatty acid oxidation, diets were stored at -80°C and fresh food 
was provided every 24 h.  Food intake and body weights were measured weekly. 
Tissue collection and cell isolation.   After rats were killed by CO2 asphyxiation 
and cervical dislocation, the colon was removed and flushed with warm Ca2+ and Mg2+ 
free phosphate buffered saline (PBS) (GibcoBRL, Grand Island, NY).   For each rat, the 
last half of the colon was taken as distal colon.  The last centimeter of the distal colon 
was taken for histology and fixed in 4% paraformaldehyde for 4 h, followed by 
sequential washings in 50% and 70% ethanol.  The remaining colon segment was cut 
longitudinally to expose the lumen and placed in warm Ca2+ and Mg2+ free Hank's 
Balanced Salt Solution (HBSS), 30 mmol/L EDTA, 5 mmol/L dithiothreitol (DTT), 
0.1% fatty acid free BSA (w/v), 1 mmol/L glutamine and 1 mmol/L butyrate (pH 7.4).  
Following a 15 min shaking incubation, the mucosal side was gently scraped with a 
rubber policeman.  This procedure is designed to remove intact crypts and surface cells 
leaving behind the lamina propria (113).  Removal of crypts and surface cells was 
confirmed by histological examination of remaining intestinal tissue following the 
scraping procedure. The isolated crypts were then centrifuged at 100 x g and washed 
twice in warm HBSS containing Ca2+, Mg2+, 0.1% BSA (w/v), 1 mmol/L glutamine, and 
1 mmol/L butyrate.  An aliquot of cells from the distal colon was taken for antioxidant 
enzyme analysis and Fragment Length Analysis using Repair Enzymes (FLARE). 
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Measurement of apoptosis using the TUNEL assay.  Paraffin sections of the 4% 
paraformaldehyde fixed tissues were utilized for in situ measurement of apoptosis using 
ApopTag kits (Intergen, Purchase, NY) as previously described (139).  This technology 
is based on the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-
labeling (TUNEL) technique.  Intestinal crypts were scored according to positive 
staining by DAB and morphological criteria previously described by Kerr et al. (140).  
Apoptotic index for each crypt was determined by dividing the number of apoptotic cells 
in a crypt column by the crypt column height (# of cells).  The mean apoptotic index of 
25 crypts within a tissue was used as the apoptotic index for that tissue. 
Measurement of antioxidant enzyme activity.  Activities of CAT, GPx, and SOD 
in isolated colonocytes were measured spectrophotometrically using commercial assay 
kits (Calbiochem, San Diego, CA).  Cell lysates were prepared by homogenization of 
cells in 50 mmol/L potassium phosphate buffer (250 mmol/L sucrose, 1 mmol/L EDTA, 
1 mmol/L DTT, 0.1% Triton X-100 (v/v)) followed by centrifugation for 3 min at 10,000 
x g.  Supernatant was used for enzyme assays following protocols provided in each kit.  
Briefly, SOD activity was determined by measuring the rate of generation of a 
chromophore at 525 nm.   CAT activity was determined by measuring absorbance of 
quinoneimene dye at 520 nm.  GPx was determined indirectly by oxidation of NADPH 
to NADP+ measured at 340 nm using H2O2 as the preferred substrate.  Sodium azide 
(NaN3) was used to inhibit catalase competition for H2O2.  Samples were analyzed in 
triplicate in 96 well microplates with standards provided in kits or purchased separately 
from Calbiochem.  Microplates were read on a Spectra Max 250 microtiter plate reader 
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using SoftMax Pro v.1.2 software (Molecular Devices, Sunnyvale, CA).  Activity was 
normalized to protein concentration as determined by Commassie Blue assay (Pierce, 
Rockford, IL). 
Detection of reactive oxygen species.  Samples of isolated colonocytes 
(maintained at 37°C) were prepared in duplicate and incubated for 15 min with 
chloromethyl -2’,7’-dichlorodihydrofluorescein diacetate (CM-H2DCFDA, Molecular 
Probes, Eugene, OR), a fluorescence probe sensitive to such cellular oxidants as 
hydrogen peroxide (H2O2), hydroxyl radicals (OH•), and peroxyl radicals (OOH•). This 
probe passively diffuses into cells and upon oxidation by ROS forms a fluorescent 
adduct, which remains trapped in the cell.  Fluorescence was monitored on a Meridian 
Ultima confocal microscope (Meridian Instruments, Okemos, MI) with a 530 nm barrier 
filter and laser excitation at 488 nm, as previously described (115).  Fluorescence 
intensity was used as an indirect measure of ROS prevalence.  Data for each sample 
were collected from 15 fields/treatment for each rat.  Viability of the cells used for 
analysis was determined after each treatment by staining with ethidium homodimer–1 
(Molecular Probes).  Mean viability was 81 ± 4.5% (n=60). 
Measurement of oxidative DNA damage using the FLARE assay.   This assay 
is a modification of single cell gel electrophoresis which uses E. Coli 
formamidopyrimidine-DNA glycosylase (fpg) to introduce DNA strand breaks 
specifically at 8-hydroxydeoxyguanosine (8-OHdG) adducts (79,141), a prevalent and 
potentially mutagenic oxidative DNA adduct (77).  This process measures the levels of 
8-OHdG on a single cell level in intact nuclei (114).  8-OHdG adducts were quantified 
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using a comet assay kit (Trevigen, Gaithersburg, MD). After isolation, crypts were kept 
at 4°C for the entire procedure to minimize DNA repair and were dispersed into single 
cells by repeated aspiration through a 27-gauge needle and plated with agarose in 
duplicate on comet slides.  Slides were exposed to lysis buffer (1% sodium lauryl 
sarcosinate (v/v), 2.5 mol/L NaCl, 100 mmol/L EDTA, 1% Triton X-100 (v/v), 10 
mmol/L Tris base, pH 10) to remove the outer cell membrane leaving only intact nuclei.  
Slides were then immersed in 1X FLARE buffer (10 mmol/L HEPES-KOH, 100 
mmol/L KCl, pH 7.4) followed by the addition of the fpg enzyme (Trevigen) diluted 
1:50 with reaction buffer (25X FLARE buffer, 100X BSA).  Control slides received only 
reaction buffer without the fpg enzyme.  Following treatment with alkali solution (1 
mmol/L EDTA, pH 12.5) to denature DNA strands, slides were exposed to 
electrophoresis (1 V/cm, 20 min) and immersed briefly in 70% ethanol (v/v).  Nuclei 
were viewed by epifluorescence microscopy using SYBR green staining (Molecular 
Probes).  Quantitation of the relative tail moment (tail moment/(tail moment + head 
moment)) (78) was measured using Metamorph software (Nikon, Garden City, NY).  
One hundred randomly selected cells were analyzed per treatment group for each rat. 
Statistical analysis.  Analysis of ROS, antioxidant enzyme activity and oxidative 
DNA damage was performed by mixed model analysis of variance (ANOVA) using 
SAS 8.0 (SAS Institute, Inc.).  Apoptotic indices were analyzed with Poisson regression 
using Proc Genmod.  The relationship between antioxidant enzymes and ROS was 
determined by regression analysis in SPSS.  The relationship between ROS and 
oxidative DNA damage was examined by regression analysis using the generalized 
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estimation equation approach with an identity link (142).  The covariates considered in 
the model included the combinations of oil and fiber as well as oxidative DNA damage 
nested within these treatment combinations.  To explain the relationship of ROS and 
apoptotic index, the linear relationship between the log-transformed apoptotic index and 
ROS levels was modeled.  To reduce the influence from potential outlying observations, 
a robust regression using Huber’s weight function was performed (143).  Results were 
considered significant at p<0.05. 
 
Results 
Food intake and body weight gain.  There were no significant differences in 
food intake or body weight gain among the experimental groups (results not shown). 
Apoptosis.  The combination of dietary fish oil and pectin yielded a greater 
apoptotic index as compared to the other experimental diets (p<0.008) (Figure 5).  These 
results are in agreement with previous findings from our laboratory in which a diet of 
fish oil and pectin enhanced apoptosis during experimentally induced colon cancer 
(49,64). 
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FIGURE 5  Rats fed fish oil and pectin displayed a greater apoptotic index as compared to other dietary 
treatments of corn oil/cellulose, corn oil/pectin and fish oil/cellulose.  Data are means ± SEM from 25 
crypts for n=15 rats/diet.  Apoptotic index represents the total number of apoptotic cells in a crypt 
column/total number of cells in the crypt column.  Bars with different letters are significantly different 
(p<0.008). 
 
 
Antioxidant enzyme activity.  The activity of CAT in colonocytes was lower 
(p<0.006) in diets containing pectin as the fiber source as compared to cellulose (results 
not shown).  Furthermore, the combination of fish oil with pectin resulted in 75% less 
CAT activity (p<0.003) and 35% less SOD activity (p<0.05) than a diet containing corn 
oil and cellulose (Figure 6A).  There was no diet effect on GPx.  Since SOD and CAT 
act sequentially in a pathway of ROS elimination, we expressed the data as enzyme 
activity ratios.  In diets containing pectin as the fiber source, the mean ratio of 
SOD/CAT was greater relative to the cellulose containing diets (SOD/CAT  = 1.7 and 
0.7, respectively) (p<0.02).  A similar trend (p=0.06) was seen with respect to dietary 
fish oil (SOD/CAT = 1.6) and corn oil (SOD/CAT = 1.0).  When the combination of 
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lipid and fiber was considered, as expected, the combination of fish oil and pectin 
yielded a greater SOD/CAT ratio (2.2) than the combination of corn oil and cellulose 
(0.6) and fish oil and cellulose (0.9) (p<0.02) (Figure 6B).   
 
0
2
4
6
8
1 0
1 2
1 4
1 6
E
nz
ym
e 
ac
tiv
ity
 (U
ni
ts
/m
g 
pr
ot
ei
n)
.
[G
Px
 (m
U
/m
g 
pr
ot
ei
n)
]
FC FP CC CP FC FP CC CP FC FP CC CP 
SOD CAT GPx 
* *
A 
 
 
 
 
B 
0.0
0.5
1.0
1.5
2.0
2.5
3.0
Corn Oil/
Cellulose
Corn Oil/
Pectin
Fish Oil/
Cellulose
Fish Oil/ 
Pectin
SO
D
/C
A
T
 r
at
io
b 
ab 
a 
a 
 
 
 
 
 
 FIGURE 6  CAT and SOD activity are diminished and SOD/CAT is elevated in rat colonocytes by 
dietary fish oil in combination with pectin.  Data are means ± SEM from n=10 rats/diet with samples read 
in triplicate.  * in panel A represents enzyme activity significantly less than the corn oil and cellulose diet 
(SOD p<0.05; CAT p<0.003).  Bars with different letters in panel B are significantly different (p<0.02). 
Abbreviations:  CC=Corn oil/Cellulose, CP=Corn oil/Pectin, FC=Fish oil/Cellulose, FP=Fish oil/Pectin. 
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Reactive oxygen species.   ROS levels in colonocytes were greater in rats 
consuming fish oil compared to corn oil (p<0.02, Figure 7). Dietary fiber did not 
significantly alter ROS levels, nor did the combination of oil and fiber. 
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FIGURE 7  Dietary fish oil elevates ROS generation in rat colonocytes.  All samples were prepared in 
duplicate. Data are main effect means ± SEM from n=15 rats/oil or fiber group with 15 fluorescence 
images captured/rat.  Bars with different letters are significantly different within that panel (p<0.05). 
 
 
Relationship between ROS, apoptosis and oxidative DNA damage.  Regardless 
of diet, there was an exponential relationship between ROS and apoptosis (Figure 8).  As 
the levels of ROS rise in rat colonocytes, the apoptotic index rises exponentially 
(p<0.005).  Across all diets, there was no difference in overall levels of oxidative DNA 
damage as determined by quantification of 8-OHdG adducts.  However, upon 
examination of the relationship of oxidative DNA damage to ROS levels within a rat, 
there were distinct diet differences (Figure 9).  In rats consuming the fish oil and pectin 
diet, oxidative DNA damage was inversely related to ROS level (p<0.0001), indicating 
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that as the level of ROS increased, there was a decrease in the level of oxidative DNA 
damage.  In contrast, rats consuming the other experimental diets did not exhibit this 
inverse relationship.  In fact, the relationship of ROS and oxidative DNA damage in the 
corn oil and cellulose diet was significantly different from the fish oil and pectin diet 
(p<0.002). 
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FIGURE 8  Elevation in ROS corresponds to the exponential increase in apoptotic index in rat 
colonocytes.  Data are from n=20 rats (10 fish oil/pectin, 10 corn oil/cellulose) with 15 fluorescence 
images captured/rat for ROS and 25 crypts/rat for apoptosis.  Apoptotic index was calculated as total 
number of apoptotic cells in a crypt column/total number of cells in the crypt column.  Equation for the 
exponential relationship is y = exp(-1.9611 + 0.0011 x ROS) – 0.25. 
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FIGURE 9  Oxidative DNA damage was inversely associated with ROS production in colonocytes from 
rats receiving the fish oil/pectin diet.  Data are from n=26 rats with 100 cells/rat analyzed for oxidative 
DNA damage and 25 crypts/rat for apoptosis.  Apoptotic index was calculated as total number of apoptotic 
cells in a crypt column/total number of cells in the crypt column.  The fish oil pectin correlation was 
significant (p<0.0001, r=0.75).  The corn oil cellulose correlation was not significant (ns, r=0.53). The 
slopes of the two lines are significantly different (p<0.002). 
 
 
Discussion 
Apoptosis has been shown to be one of the most critical control processes in 
cancer prevention and treatment (144).  In fact, induction of apoptosis is the primary 
mode of action for most chemotherapeutic drugs and radiation.  Therefore, the ability of 
dietary fish oil in combination with pectin to enhance apoptosis, as shown here and in 
previous studies (49,132), may be a critical mechanism by which this diet is able to 
prevent colon cancer.  The specific pro-apoptotic actions of dietary fish oil and pectin 
are not well characterized; however, the initiation and regulation of apoptosis appears to 
be intimately associated with modifications in the oxidative environment (9,69).  The 
balance of ROS generation and antioxidant capacity within the cell determines the 
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oxidative environment.  When ROS exceed the antioxidant capacity of the cell, oxidative 
stress results.  Oxidative stress can initiate and/or mediate a number of signaling 
cascades, including apoptosis.  Thus a potential mechanism whereby fish oil and pectin 
may initiate apoptosis is via alterations in the cellular redox balance.  We have 
previously shown dietary fish oil to enhance ROS generation in colonocytes (50); 
however, we did not consider the antioxidant response.  The intent of this study was to 
use primary cultures from an in vivo rat model to determine the ability of dietary fish oil 
and pectin to modulate cellular ROS and antioxidant capacity to promote apoptosis. 
Important determinants of cellular antioxidant capacity are the enzymes SOD, 
CAT and GPx which are responsible for the elimination of ROS.  As these enzymes act 
sequentially to remove ROS, the balance of the activity of these enzymes may be as 
critical in the defense against ROS as the activity of the enzymes alone (145).  Data from 
this experiment show the activity of these enzymes, especially CAT, to be influenced by 
dietary fiber.  Specifically, antioxidant enzyme activity in colonocytes from rats 
receiving a pectin diet was less than that observed in the cellulose diets.  Furthermore, 
the combination of fish oil with pectin in the diet resulted in even lower activity for CAT 
and SOD.  Interestingly, the difference in CAT activity was greater than the change seen 
with SOD, suggesting a possible enzyme activity imbalance.  SOD converts superoxide 
(O2•-) to H2O2, which is then converted to water and/or O2 by CAT & GPx.  Thus, 
dramatically diminished CAT activity coupled to only a subtle reduction in SOD (an 
increase in SOD/CAT) may yield a system that can no longer eliminate H2O2 at the rate 
it is formed.  Indeed, dietary pectin and to a lesser extent dietary fish oil elevate the 
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SOD/CAT ratio compared to cellulose and corn oil, respectively.  Furthermore, the 
greatest enhancement in SOD/CAT was seen when fish oil and pectin were combined in 
the diet.  Similar experiments in rat colonocytes have found dietary fish oil to reduce 
antioxidant enzyme activity (107) and a recent dietary intervention trial showed diets 
high in fiber and (n-3) PUFAs are capable of reducing antioxidant enzyme activity in 
humans (108).  Although the mechanism by which these dietary constituents achieve a 
reduction in enzyme activity is unclear, these results suggest that dietary lipid and 
dietary fiber, specifically fish oil and pectin, work coordinately to alter antioxidant 
enzyme activity and balance in a manner that may create a pro-oxidant environment in 
the colonocytes.  
ROS measurements further suggest that dietary fish oil may create a more 
oxidative environment in the colonocytes as compared to a corn oil diet.  Diets with fish 
oil as the lipid source enhanced ROS generation in the colonocytes.  This is not 
unexpected considering the high degree of unsaturation found in the long chain (n-3) 
PUFAs in fish oil.  The primary (n-3) fatty acids in fish oil, eicosapentaenoic acid 
(20:5(n-3)) and docosahexaenoic acid (22:6(n-3)) have up to three times as many double 
bonds per molecule than the (n-6) fatty acids found in corn oil, such as linoleic acid 
(18:2(n-6)).  This increases the opportunity for oxidant attack and can contribute to the 
propagation of ROS.  Furthermore, we have shown dietary (n-3) PUFAs to be readily 
incorporated into the mitochondrial membrane (146), predisposing the mitochondria to 
enhanced lipid peroxidation and membrane damage and contributing to the propagation 
of ROS generated by the mitochondrial electron transport system (50).  It is likely that 
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many of the fatty acids consumed in these experimental diets maintained a high degree 
of unsaturation as the diets were kept at -80°C to prevent fatty acid oxidation.  However, 
these conditions may not be practical outside of the laboratory setting and less than 
optimal storage may enhance the degree of fatty acid oxidation prior to consumption.  
This may have a significant impact on the physiological effects of dietary lipid and 
definitely warrants further attention. 
Although dietary fish oil and pectin alter the antioxidant capacity and ROS 
generation of colonocytes to favor a pro-oxidant environment, the outcome of these diet-
induced cellular modifications are critical.  An oxidative environment may favor 
apoptosis, or alternatively, may increase the potentially mutagenic event of damaging 
DNA.  Therefore, it was important to determine apoptosis and oxidative DNA damage in 
the same animals in which the diet-induced changes in ROS and antioxidant enzyme 
activity were measured.  In the fish oil/pectin diet, apoptosis was enhanced and the 
oxidative environment created by this diet was associated with a decline in oxidative 
DNA damage.  Alternatively, in the corn oil/cellulose diet, apoptosis was less than in the 
fish oil/pectin diet and as ROS increased, oxidative damage did not decrease as seen in 
the fish oil/pectin diet.  Thus, the suppression of oxidant protection systems and 
enhancement of ROS generation by dietary fish oil and pectin appears to protect the 
colon against oxidative DNA damage by promoting ROS-mediated apoptosis.  However, 
continued investigation is needed to further elucidate the multi-faceted relationship 
between cellular redox status and apoptosis.  Additional investigation is also necessary 
to determine if these dietary modifications of the redox environment and the resulting 
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increase in apoptosis continues during the initiation and progression stages of colon 
carcinogenesis.  While we have previously shown apoptosis to be enhanced by dietary 
fish oil and pectin during the initiation (64) and progression (49) of colon 
carcinogenesis, whether or not the mechanism is alteration of the redox environment 
remains to be determined. 
In summary, dietary fish oil and pectin work coordinately to enhance colonocyte 
apoptosis by modulation of the cellular redox environment.  In this ex vivo model, we 
showed dietary fish oil to enhance ROS in colonocytes while the effects of dietary pectin 
were more clearly seen in the attenuation of antioxidant enzyme activity.  Therefore, it is 
not surprising that the combination of these dietary constituents work in concert to create 
an environment permissive for apoptosis, thereby protecting cells from severe and 
possibly mutagenic DNA damage.   This study reinforces the importance of diet for the 
prevention of cancer and strengthens the growing realization that the effects of 
individual diet components may not be as significant as the combination of foods that 
are consumed in the diet.  Further investigations should evaluate the influence of other 
components of the diet matrix as well as the impact of alterations to diet components 
(e.g., fatty acid oxidation prior to consumption).  
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CHAPTER IV 
DIETARY FISH OIL AND PECTIN SUPPRESS OXIDATIVE DNA 
DAMAGE AND ENHANCE APOPTOSIS TO PROTECT AGAINST 
RADIATION-ENHANCED COLON CARCINOGENESIS IN THE 
INITIATION STAGE 
 
One of the primary goals of NASA’s vision for space exploration is to “extend 
human presence across the solar system (147).”  However, there are many risks 
associated with extended time in space, one of the most serious being exposure to 
cosmic radiation.  Prolonged exposure to high energy cosmic radiation, such as would be 
found in outer space, can cause severe and possibly irreparable physiological damage 
including damage to DNA that can lead to mutation and cancer (10).  Therefore, 
countermeasures to radiation damage must be found before long-term space flight is 
safely achievable.  Dietary modification is one reasonably attainable countermeasure. 
A wealth of evidence has shown that modification of dietary fat and fiber can 
significantly alter the risk of colon cancer (27), one of the leading causes of cancer death 
in the US (1) and one of the most preventable by diet (2).  We have shown a diet rich in 
n-3 PUFAs (such as those found in fish oil) in combination with the fermentable fiber, 
pectin, to be protective against an experimental model of colon carcinogenesis in rats 
(49).  Furthermore, this protective effect is consistent through each stage of 
carcinogenesis, from initiation to tumor formation (135,139).  In contrast, diets rich in n-
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6 fatty acids and the poorly fermentable fiber, cellulose, appear to promote colon 
tumorigenesis.  Recently, Hong et al. demonstrated that the dietary combination of fish 
oil and pectin is protective in the initiation stage of colon carcinogenesis by minimizing 
DNA damage and enhancing apoptosis, a form of programmed cell death (64).  It has 
been further suggested that this enhancement of apoptosis may be due to the ability of 
dietary fish oil and pectin to modulate the oxidative environment of the colon (148).   
Radiation exposure also modulates the cellular oxidative environment.  Radiation 
is considered a carcinogen by its ability to cause genetic mutations primarily through 
DNA single and double strand breaks.  However, radiation exposure can also result in 
the generation of reactive oxygen species which creates a secondary mechanism by 
which radiation may damage DNA (10).  This secondary mechanism is not as well 
characterized as DNA strand breaks, even though it may play a critical role in 
carcinogenesis.  Furthermore, the ability of diet to protect against radiation-induced 
DNA damage is not widely investigated.  We have shown dietary fish oil and pectin to 
protect against DNA damage caused by a chemical carcinogen via modulation of the 
colonocyte redox environment to enhance apoptosis (64).  This dietary combination may 
also be able to protect against radiation-induced DNA damage by a similar mechanism.  
In addition, it is reasonable to expect that astronauts may not only be exposed to 
radiation, but also to chemical carcinogens upon their return to earth and that the 
combined effect may be more severe than either carcinogen alone. Thus, it is also critical 
to investigate the ability of diet to protect against the combination of radiation and 
chemical carcinogen. 
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As we have previously shown the combination of dietary fish oil and pectin to 
protect against a chemical carcinogen in the initiation stage of colon carcinogenesis, we 
hypothesized that this diet will also protect against the added insult of high energy 
radiation exposure.  In addition, we proposed that the protective mechanism of this diet 
is through modification of the cellular redox environment to minimize oxidative DNA 
damage and enhance apoptosis. 
 
Materials and Methods 
Animals and diets.  Animal use was approved by the University Animal Care 
Committee of Texas A&M University and conforms to National Institutes of Health 
guidelines (NRC 1985).  One hundred sixty male weanling (28-d old) Sprague-Dawley 
rats (Harlan Sprague Dawley, Houston, Texas) were housed individually in raised wire 
cages to diminish coprophagy and maintained in a temperature- and humidity-controlled 
animal facility with a daily photoperiod of 12 h light and 12 h dark.  The rats were 
stratified by body weight and assigned to one of four experimental diets (40 rats/diet), 
which were consumed for 31 d.  This study represents a 2 x 2 x 2 factorial design with 
two treatments (irradiated and non-irradiated), two types of fat (corn oil or fish oil) and 
two types of fiber (cellulose or pectin).  Dietary composition included 15% dietary fat by 
weight (30% kcals from fat) and 6% dietary fiber by weight (equivalent to 30 g fiber/d in 
a human diet).  The fish oil diet contained 3.5 g of corn oil/100 g diet to prevent essential 
fatty acid deficiency (48). The types of fiber were chosen based on their fermentability 
with cellulose being poorly fermentable and pectin being highly fermentable (112).  To 
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ensure equal antioxidant content in all diets, fish oil was supplemented with α-
tocopherol, γ-tocopherol and tert-butyl hydroquinone equal to the levels found in corn 
oil.  Food and water were freely available.  To minimize fatty acid oxidation, diets were 
stored at -80°C and fresh food was provided every 24 h.  Food intake over 48 h and body 
weights were measured prior to carcinogen injection. 
After 21 d of receiving experimental diet, 60 rats were exposed to 1 Gy of 1 
GeV/nucleon Fe ion radiation at the AGS facility of Brookhaven National Laboratory 
(Upton, New York).  The beam was targeted to the abdomen of the rats to include 
irradiation of the small and large intestine.  Ten days post-irradiation the rats received 
subcutaneous injections of the colon specific carcinogen, azoxymethane (AOM), at 15 
mg/kg body weight.  The remaining rats (n=100) were not exposed to irradiation but 
were injected with AOM at the same time point (day 31).  Rats were then killed by CO2 
asphyxiation and cervical dislocation at 0, 6, 9, 12 and 24 h post-AOM injection (n=20 
non-irradiated rats/timepoint, n=12 irradiated rats/timepoint).  The zero hour timepoint 
was used as a negative control as these rats were not injected with AOM. 
Cell isolation.  Following termination by CO2 asphyxiation and cervical 
dislocation, the colon was removed (cecum to rectum) and cut longitudinally to expose 
the lumen.  Two centimeters of the most distal colon were fixed in 4% PFA or 70% 
ethanol (1 cm/fixation).  The mucosal layer of the remaining colon was removed by 
scraping with a glass slide and a small amount (5-20 mg) was used for glutathione 
(GSH) analysis.  
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Measurement of apoptosis using the TUNEL assay.  Paraffin sections of the 4% 
paraformaldehyde fixed tissue were utilized for in situ measurement of apoptosis using 
ApopTag technology (Intergen, Purchase, NY) as previously described (139).  Colon 
crypts were scored according to positive staining by DAB and morphological criteria 
previously described by Kerr et al. (140).  Apoptosis was measured in rats not receiving 
AOM (0 h timepoint) and at 12 h post AOM injection, as this is the peak time for 
apoptosis following this carcinogen insult.  Apoptotic index for each crypt was 
determined by dividing the number of apoptotic cells in a crypt column by the crypt 
column height (# of cells).  The mean apoptotic index of 25 well-oriented crypts was 
used as the apoptotic index for that rat. 
Determination of GSH/GSSG.  The ratio of glutathione to glutathione disulfide 
(GSH/GSSG), a highly sensitive indicator of cellular redox status (103), was determined 
by HPLC using fluorescence detection of dansyl derivatives from samples of scraped 
mucosa based on a protocol from Jones et al. (149).  Briefly, the tissue (and a 50 µmol/L 
GSH and GSSG standard) was homogenized in preservation solution (100 mmol/L boric 
acid, 100 mmol/L sodium tetraborate, 10 mg/ml L-serine, 1 mmol/L BPDS, 10 mmol/L 
iodoacetic acid) and an equal volume of perchloric acid solution (10% w/v) followed by 
centrifugation at 10,000 x g for 1 min.  Derivatization was completed by exposure of the 
supernatant to dansyl chloride for 18-24 h.  Following choloroform extraction, 20 µL of 
the clear upper layer was injected into the autosampler and separated by passing through 
a 3-aminopropyl column (5 µm; 4.6 mm X 25 cm; Custom LC, Houston, Texas) at a 
flow rate of 1 ml/min.  A linear gradient of 80% (v/v) methanol and acetate buffer 
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(pH=4.6) was run over 45 min to achieve separation.  Dansyl derivatives were detected 
by fluorescence monitoring with 335 nm excitation and 610 nm emission.  GSH and 
GSSG were measured at each of the five timepoints in the initiation timeframe. 
Immunohistochemical analysis of 8-hydroxy-deoxyguanosine (8OHdG) 
adducts.  Paraffin sections of the 70% ethanol fixed tissue were utilized for in situ 
measurement of 8OHdG adducts using anti-8OHdG from Oxis International and a 
protocol adapted from Tanaka et al. (86).  This antibody has a high specificity for the 
8OHdG adduct and low cross reactivity with other modified bases (87).  Following 
deparaffinization with xylene and ethanol, slides were incubated with Dnase-free RNAse 
(Ambion, Austin, TX) at 37°C to eliminate RNA adduct interference.  DNA was 
denatured by incubating in 4 mol/L HCl and non-specific binding of the secondary 
antibody was blocked with 10% rabbit serum.  Anti-8OHdG (1:20 in 1% rabbit serum) 
was applied to the slides and incubated at 4°C overnight.  Biotinylated rabbit anti-mouse 
(Jackson Immunoresearch, West Grove, PA) (1:800 in 1% rabbit serum) was used as the 
secondary antibody.  Endogenous peroxidases were quenched and the slides then 
incubated with avidin-biotin horseradish peroxidase (ABC-HRP) (Vector Laboratories, 
Burlingame, CA).  DAB with H2O2 was used for detection of adducts.  8OHdG adducts 
were measured in rats not receiving AOM (0 h timepoint) and at 12 h post AOM 
injection in correspondence with apoptosis measurements.  The staining intensity of each 
cell within a crypt column was determined using NIH Image software.  The mean stain 
intensity was determined for each crypt column and fifteen crypt columns were analyzed 
in each rat. 
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Statistical analysis.  Analysis of intake, weight change, oxidative DNA damage, 
apoptosis, GSH, GSSG and GSH/GSSG was performed by mixed model analysis of 
variance (ANOVA) using SAS 8.0 (Sas Institute, Inc.).  A log transformation was used 
in the analysis of GSH/GSSG.  A Poisson regression was used to analyze the difference 
in apoptosis prior to and after AOM treatment.  Results were considered significant at 
p<0.05. 
 
Results 
Food intake and body weight gain.  There were no differences in weight gain 
between irradiated and non-irradiated animals or among the diet groups.  Intake was also 
similar among the diet groups, but interestingly, irradiated rats consumed significantly 
more than non-irradiated rats (p<0.001) (results not shown). 
Apoptosis.  As expected, apoptotic index increased 12 hours after administration 
of AOM regardless of radiation or diet treatment (p<0.0001).  Radiation alone (as 
measured at time 0) was not sufficient to enhance apoptosis.  When radiation was 
combined with AOM, apoptosis was enhanced compared to non-irradiated, AOM 
injected rats, but only in rats consuming pectin diets (p<0.04) (Figure 10).  Additionally, 
pectin fed rats exposed to radiation and AOM had significantly greater apoptosis than 
cellulose fed rats within the same treatment group (p<0.03).  There was no effect of 
dietary fat on apoptotic index.  Thus, irradiated rats fed corn oil & pectin had a similar 
apoptotic index as rats fed fish oil & pectin. 
 
 63
 
0
1
2
3
4
5
6
7
Cellulose Pectin
A
po
pt
ot
ic
 in
de
x 
(%
)
Non-irradiated
Irradiated
b 
a a ab 
 
 
 
 
 
 
 
 
FIGURE 10  Irradiated rats fed pectin have greater apoptosis than non-irradiated pectin fed rats and 
irradiated cellulose fed rats at 12 h post AOM.  Data are means ± SEM for n=10 rats/fiber in the non-
irradiated group and n=6 rats/fiber in the irradiated group).  Apoptotic index was measured at 12 h post 
AOM injection.  Bars with different letters are significantly different (p<0.04). 
 
 
GSH and GSSG.  In response to radiation and prior to chemical carcinogen 
treatment, fish oil fed rats displayed an increase in GSH/GSSG which was significant in 
the fish oil and pectin diet (p=0.05) (Figure 11A).  This change in the redox environment 
was not seen in the corn oil diets.   After treatment with a chemical carcinogen (all 
timepoints considered), the irradiated rats fed fish oil and pectin continued to maintain 
elevated GSH/GSSG, compared to the other diet groups (p<0.05) (Figure 11B).  This 
elevation in GSH/GSSG may be due, in part, to a decrease in GSSG levels (p<0.05) 
since there was no change in GSH (Figure 12).  No diet effects in GSH/GSSG or GSSG 
were observed in non-irradiated animals. 
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FIGURE 11  Fish oil and pectin fed rats displayed a more reduced environment (increase in GSH/GSSG) 
in response to radiation (Panel A) and the combination of radiation and AOM (Panel B).  Data in panel A 
are geometric means ± SEM for 32 rats (n=3/diet in the irradiated group and n=5/diet in the non-irradiated 
group).  Data in panel B are geometric means ± SEM for 160 rats (n=15/diet in the irradiated group and 
n=25/diet in the non-irradiated group).  * represents significant difference from non-irradiated within the 
same diet group (p≤0.05). Bars with different letters are significantly different from irradiated rats in other 
diet groups (p<0.05). 
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FIGURE 12  Irradiated rats fed fish oil and pectin had lower levels of GSSG prior to AOM treatment  
compared to corn oil diets (Panel A) and maintained lower levels following AOM treatment (Panel B).  
Data in panel A are means ± SEM for 32 rats (n=3/diet in the irradiated group and n=5/diet in the non-
irradiated group).  Data in panel B are means ± SEM for 160 rats (n=15/diet in the irradiated group and 
n=25/diet in the non-irradiated group). Bars with different letters are significantly different from irradiated 
rats in other diet groups (p<0.05). 
 
Oxidative DNA damage.  Radiation alone did not increase 8OHdG DNA adducts 
in rat colonocytes as determined by immunohistochemistry.  AOM treatment did 
increase the formation of 8OHdG adducts by 12 h post AOM in non-irradiated rats 
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(p<0.02) (Figure 13A).  However, in irradiated rats, the increase in 8OHdG from AOM 
administration was only significant in corn oil and pectin fed animals (p<0.009) (Figure 
13B). 
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FIGURE 13  Irradiated rats fed corn oil and pectin experience greater levels of 8OHdG 12 h post AOM 
injection compared to prior to AOM.   Panel A displays the effect of AOM on 8OHdG in non-irradiated 
rats. Data are means ± SEM for n=5 rats/timepoint/diet.  Bars with different letters are significantly 
different within that diet (p<0.02). Panel B displays the effect of AOM on 8OHdG in irradiated rats.  Data 
are means ± SEM for n=3 rats/timepoint/diet.  Bars with different letters are significantly different within 
that diet (p<0.009). 
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Discussion 
The classification of high energy radiation as a carcinogen is based on its ability 
to severely damage DNA (10).  While the most common form of damage to DNA from 
radiation is the formation of double strand breaks, there are also more indirect and 
lasting effects that may be just as potentially mutagenic.  One of these indirect effects is 
the generation of reactive oxygen species leading to cellular oxidative stress and 
enhancement of oxidative DNA damage (23).  Oxidative DNA damage, specifically the 
8OHdG DNA adduct investigated in this study, has been implicated in the carcinogenic 
process (9).  In fact, 8OHdG has been cited as the possible source of commonly found 
mutations in ras and p53 present in colorectal cancer (9).  Several investigations have 
shown enhanced urinary excretion of 8OHdG immediately following space flight, 
indicating an increase in oxidative DNA damage following exposure to high energy 
radiation (150).  In this investigation, we did not find 8OHdG to be enhanced at 10 d 
post irradiation, suggesting that cellular mechanisms are in place to repair or remove 
damaged DNA bases soon after a radiation insult.  A similar finding was seen by Stein et 
al. who showed an initial non-significant increase in 8OHdG following radiation 
exposure, but a return of 8OHdG to pre-radiation exposure levels at 12-14 d post 
irradiation (150).   
One mechanism by which radiation-induced DNA damage may be removed is 
apoptosis.  This form of programmed cell death occurs fairly rapidly in colonocytes 
following an insult, such that the normal rate of cell turnover is restored approximately 
24 h after radiation exposure (6).  This rapid response to radiation injury and early 
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elimination of severely damaged cells is most likely why there was not an elevation in 
apoptosis observed in these rats at 10 d post irradiation.   
Although there was no change in oxidative DNA damage or apoptosis following 
irradiation and prior to AOM, there was a dietary modification of the redox environment 
in response to radiation as demonstrated by a change in GSH/GSSG.  Other investigators 
have also shown redox changes to persist in the progeny of irradiated cells, contributing 
to a genomic instability and increasing the likelihood of future mutations (23,151).  
Glutathione (GSH), a low molecular weight thiol, is highly sensitive to changes in the 
oxidative environment, and changes in the ratio of GSH to its oxidized form (GSSG) is 
often used as an indicator of cellular redox status (103).  The environment in fish oil fed 
rats was more reduced (greater GSH/GSSG) following irradiation than non-irradiated 
rats and this was most pronounced in the fish oil/pectin diet.  Furthermore, elevations in 
GSH/GSSG were maintained in rats fed a fish oil and pectin diet even after treatment 
with AOM.  This change in GSH/GSSG seen in the fish oil diets appears to be due to a 
reduction in the levels of cellular GSSG rather than an increase in GSH.  As a more 
reduced environment is better able to endure an oxidative stress without severe damage 
to the cell, colonocytes from rats fed fish oil and pectin may be better prepared for future 
oxidative attacks.   
This is of critical importance as astronauts, upon their return to earth, will likely 
be exposed to numerous carcinogens in the environment and previous radiation exposure 
may make their cells more susceptible to damage by chemical carcinogens.  Indeed we 
demonstrate here that treatment with AOM triggered an increase in 8OHdG adducts. Yet 
 69
in irradiated rats, this AOM-induced increase in 8OHdG adducts is only significant in 
rats fed corn oil and pectin. The combination of fish oil with pectin did not elicit this 
significant increase in oxidative damage and this may be due to the more reduced redox 
environment (elevated GSH/GSSG) present among irradiated rats fed this diet.  
Nevertheless, dietary pectin was able to enhance colonocyte apoptosis in rats receiving 
either lipid source regardless of the differences in the oxidative environment.  Apoptosis 
was enhanced in irradiated rats fed pectin compared to non-irradiated rats also receiving 
pectin as a fiber source.  Furthermore, irradiated rats fed pectin experienced more 
apoptosis than cellulose fed rats.  Yet, the enhancement of apoptosis in the fish oil and 
pectin diet was not coupled with an increase in oxidative DNA damage as was seen in 
the corn oil and pectin diet.   Thus, the combination of fish oil with pectin is able to 
enhance colonocyte apoptosis while simultaneously maintaining a more protective (i.e. 
more reduced) cellular environment to promote less oxidative DNA damage. 
Therefore, it appears that the more reduced environment created by fish oil in 
response to radiation is better prepared for the additional stress of a subsequent 
carcinogen insult and thereby more effectively attenuates the increase in oxidative DNA 
damage.  Additionally, the more oxidative environment in corn oil fed rats may 
predispose the colonocytes to more severe increases in oxidative DNA damage in 
response to a chemical carcinogen.  Another investigation in cell culture using free 
radical scavengers to promote a less oxidatively stressful environment during irradiation 
also found a reduction in oxidative DNA damage from ROS as well as a reduction in 
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chromosomal instability (66).  We show here, the ability of dietary modification to 
achieve a similar protection from oxidative DNA damage in colonocytes.  
In summary, this investigation demonstrates the ability of diet to minimize 
oxidative DNA damage and enhance apoptosis during the initiation stage of radiation-
enhanced colon carcinogenesis.  Dietary pectin elevates colonocyte apoptosis in 
irradiated rats as compared to cellulose fed rats.  However, when pectin is combined 
with corn oil in the diet, there is a significant enhancement of oxidative DNA damage 
that is not seen when pectin is combined with fish oil.  This protective effect may be due 
in part to the ability of fish oil and pectin to promote a more reduced environment in 
response to radiation thereby preparing the colonocytes for subsequent attack by other 
carcinogens.  While several studies have examined colonocyte responses to radiation and 
chemical carcinogen individually (49,152), this is the first investigation to describe the 
combinatorial effects of these two distinct carcinogens as well as the ability of diet to 
protect against this dual insult.  These findings demonstrate the importance of diet as a 
potential countermeasure to the risks associated with radiation exposure in space flight.  
However, further investigation is needed in animal and human studies before 
recommendations can be made.  Not only can these investigations increase the safety of 
current and future space travelers, but they also may increase our understanding of diet’s 
role in the prevention of cancer. 
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CHAPTER V 
SUMMARY AND CONCLUSION 
 
For several decades, the variation in cancer susceptibility between the small and 
large intestine has intrigued scientists and prompted some to investigate the 
environmental and intrinsic differences in these two similar tissues (4,17).  A clear 
understanding of the relative resistance of the small intestine to tumorigenesis may offer 
insight into potential mechanisms of chemoprevention in the colon.  Yet, due to the 
rarity of small intestine cancer, research is limited and several of the proposed 
differences provide only an incomplete explanation (3).  In this investigation, we 
proposed that intrinsic differences in redox status and response to oxidative stress 
contribute to differences in cancer occurrence in the small intestine and colon. 
Indeed, this study showed that basal levels of ROS were greater in the colon than 
the small intestine, and that this persisted despite elevated activity of antioxidant 
enzymes.  Considering this seemingly pro-oxidant environment, it was not surprising 
that exposure to an exogenous oxidative stress resulted in more oxidative DNA damage 
in the colon compared to the small intestine.  Exogenous stress is of greater concern for 
the large intestine which endures prolonged exposure to oxidized food particles or toxins 
in the fecal stream as well as the oxidants generated by microbial fermentation (127).  
Inability to manage exogenous stressors and the resulting increases in oxidative DNA 
damage likely contributes to the etiology of inflammatory bowel diseases and possibly 
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colon cancer (9).  Thus, these findings may contribute to the explanation of the 
difference in cancer susceptibility between the small and large intestine. 
While ROS generation may enhance oxidative DNA damage, as shown in the 
comparison of the small and large intestine, there is also considerable evidence that ROS 
are critical signaling molecules in apoptosis (69-71,73-75,137).  Our laboratory has 
previously shown the combination of dietary fish oil and pectin to enhance apoptosis in 
the colon of rats exposed to a carcinogen.  One potential mechanism by which this diet 
may induce apoptosis is via elevations in ROS.  This would not be unexpected 
considering the degree of unsaturation of n-3 PUFAs in fish oil and the rapid colonocyte 
metabolism of butyrate, a fermentation product of pectin, both of which can generate 
substantial ROS.  In this investigation, we evaluated the ability of dietary fish oil and 
pectin to modulate the colonocyte redox balance to promote apoptosis. 
As the time at which dietary interventions are initiated may influence the ability 
of the diet to protect against colon cancer (58), it was desirable to examine the effects of 
diet prior to and following a carcinogen insult.  The first portion of the experiment 
examined ROS generation, antioxidant enzyme defenses, oxidative DNA damage and 
apoptosis in a primary culture from an in vivo rat model prior to a carcinogen insult.  
Dietary fish oil and pectin did work coordinately to create a more oxidative cellular 
environment, with fish oil primarily enhancing cellular ROS while pectin attenuated 
antioxidant enzyme activity.  Despite the creation of this oxidative environment, 
oxidative DNA damage declined in the fish oil and pectin diet but apoptosis was 
enhanced.  In fact, apoptosis increased exponentially as ROS increased.  These findings 
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suggest that the combination of dietary fish oil and pectin work coordinately to create an 
environment permissive for apoptosis, thereby protecting against potentially mutagenic 
oxidative DNA damage that could lead to colon cancer. 
The next portion of this investigation examined the ability of fish oil and pectin 
to alter the colonoctye oxidative environment to promote apoptosis following exposure 
to carcinogens.  Two unique carcinogens, ionizing radiation and AOM, were used in 
combination.  Radiation is considered a carcinogen due to its ability to directly (via 
strand breaks) and indirectly (via generation of oxidative stress) damage DNA which is a 
particular concern for the space program.  One of the greatest limitations to long term 
space flight is exposure to high energy, cosmic radiation.  Thus, countermeasures to 
radiation damage must be found before extended time in space flight is safely 
achievable.  In addition, individuals returning from space flight will most likely 
encounter chemical carcinogens upon their return to the earth and the combined effect of 
radiation and chemical carcinogen may be more severe than either carcinogen alone.  
For this reason, we combined an ionizing radiation insult with our well-characterized 
model of AOM-induced colon cancer.  As we have previously shown dietary fish oil and 
pectin to protect in the initiation stages of AOM-induced colon carcinogenesis (49,64), 
we proposed that this diet would also protect against the added insult of high energy 
radiation.  Furthermore, the protective mechanism of this diet would be reflected in its 
ability to modulate the colonocyte redox environment to promote apoptosis. 
Dietary fish oil and pectin did protect against colon carcinogenesis during the 
initiation stage of radiation enhanced AOM-induced colon cancer by promoting 
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apoptosis and attenuating oxidative DNA damage.  Dietary pectin was able to enhance 
apoptosis regardless of the oxidative environment.  However, only when pectin was 
combined with fish oil was there also a less of an increase in AOM-induced DNA 
damage as compared to the combination of corn oil and pectin.  Unlike the previous 
experiment which measured ROS at only one timepoint, this study examined the change 
in the redox environment over a 24 h period using GSH/GSSG, a sensitive indicator of 
oxidative status.  In this investigation, we demonstrate that in response to radiation, the 
combination of dietary fish oil and pectin promotes a more reduced cellular environment 
(elevated GSH/GSSG) as compared to the other experimental diets.  This reduced 
environment enables the coloncytes to endure an additional stress of a chemical 
carcinogen without a significant increase in oxidative DNA damage.   
 In summary, the oxidative environment of intestinal epithelial cells is an 
important determinant in the resistance or susceptibility of a tissue to cancer 
development and the ability of dietary fish oil and pectin to favorably modulate this 
environment implicates it as an important environmental factor in colon cancer 
prevention.  While the redox environment of the small and large intestine may explain, 
in part, the difference in cancer susceptibility, it is most likely not the only determining 
factor.  Many differences have been discovered and others remain to be determined, all 
of which will continue to provide insight into the carcinogenic process in both of these 
tissues.  The findings presented here also show promise in the ability of dietary fish oil 
and pectin to protect against colon carcinogenesis.  Yet, further animal and human 
studies are necessary before recommendations can be made.  These investigations are 
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also unique in that they examine the interaction of two dietary factors rather than an 
individual dietary component.  Further studies into interactions of other diet matrix 
components may also yield more compelling evidence of the role of diet in the 
prevention of colon cancer.      
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APPENDIX A 
TABLES OF RESULTS 
 
Table A1 
GSH levels (nmol/mg protein) 
Oil, radiation, time effects 
 Corn oil Fish oil 
 0 h 6 h 9 h 12 h 24 h 0 h 6 h 9 h 12 h 24 h 
Non-
irradiated 
7.93a
± 1.58 
16.01b
± 1.58 
12.47bc
± 1.58 
9.00ac
± 1.58 
11.23ac
± 1.68 
7.54a 
± 1.68 
7.79a  
± 1.58 
9.51ac
± 1.58 
10.65ac
± 1.58 
9.79ac
± 1.58 
Irradiated 10.96
a
± 2.04 
14.71a
± 2.04 
20.71b*
± 2.28 
9.33a
± 2.04 
10.43a
± 2.28 
11.19a
± 2.04 
18.49b*
± 2.04 
11.25a 
± 2.04 
10.24a
± 2.04 
8.23a
± 2.04 
Values are means ± SEM for n=10 non-irradiated rats/timepoint/oil group and n=6 
irradiated rats/timepoint/oil group. 
In each row, means not sharing a common superscript are significantly different 
(p<0.05).  In each column, means with a * are significantly different than the other mean 
in the column (p<0.05). 
Oil*radiation*time interaction is significant (p=0.0121) 
All p-values are two-sided. 
 
 
Table A2 
GSSG levels (nmol/mg protein) 
Oil effect in both irradiated and non-irradiated rats 
 Main effect  0 h 6 h 9 h 12 h 24 h 
Corn oil 0.47  ± 0.02 
 0.46ab 
± 0.04 
0.36a 
± 0.04 
0.57b 
± 0.04 
0.49b 
± 0.04 
0.49b 
± 0.05 
Fish oil 0.37
*  
± 0.02 
 0.34a 
± 0.04 
0.36a 
± 0.04 
0.39a* 
± 0.04 
0.42a 
± 0.04 
0.34a* 
± 0.04 
Values are means ± SEM for n=16 rats/timepoint/oil group. 
In each time point row, means not sharing a common superscript are significantly 
different (p<0.05).  In each column, means with a * are significantly different than the 
other mean in the column (p<0.05).  Main effect of oil (p=0.0002). 
All p-values are 2 sided. 
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Table A3 
GSH/GSSG 
Diet, radiation, time effects 
 Non-irradiated   Irradiated
 
 
   Corn oil/ Corn oil/ 
Cellulose Pectin 
Fish oil/ 
Cellulose 
Fish oil/ 
Pectin 
Corn oil/
Cellulose 
Corn oil/ 
Pectin 
Fish oil/ 
Cellulose 
Fish oil/ 
Pectin 
0 h 19.38
a12  
± 4.46 
20.13a1  
± 4.64 
18.68a1  
± 4.30 
20.02a1  
± 5.15 
 21.61a12   
± 6.43 
19.99a1
± 5.94 
31.04a1  
± 9.23 
38.24a1  
± 11.38 
6 h 29.67
ab1  
± 6.83 
39.46a2  
± 9.09 
22.70ab1  
± 5.23 
19.87b1  
± 4.58 
 36.21ab12  
± 10.77 
21.27a1  
± 7.75 
42.96ab1  
± 12.77 
54.57b1*  
± 16.23 
9 h 17.47
a12  
± 4.02 
26.11a12  
± 6.01 
19.83a1  
± 4.57 
24.77a1  
± 5.70 
 39.43a2*  
± 14.36 
16.51b1  
± 4.91 
24.66ab12  
± 7.33 
37.78a1  
± 11.24 
12 h 14.22
a2  
± 3.27 
20.64a1  
± 4.75 
23.46a1  
± 5.40 
24.58a1  
± 5.66 
 21.23a12  
± 6.31 
17.97a1  
± 5.35 
28.30a12  
± 8.42 
26.75a1  
± 7.96 
24 h 19.37
a12  
± 4.99 
24.22a12  
± 5.58 
23.53a1  
± 5.42 
28.73a1  
± 6.62 
 17.42ab1  
± 5.18 
26.24ab1  
± 9.56 
13.86a2  
± 4.12 
31.93b1  
± 9.50 
These values are geometric means ± SEM. 
In each row, means not sharing a common letter superscript are significantly different (p≤0.05) within the irradiated or non-
irradiated group.  In each column, means not sharing a common numerical superscript are significantly different (p≤0.05). 
* indicates mean is significantly different from non-irradiated group at same timepoint and diet.  All p-values are two-sided. 
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Table A4 
Apoptotic Index 
Diet and radiation effects at 12 h post AOM 
 Corn oil/ 
Cellulose 
Corn oil/ 
Pectin 
Fish oil/ 
Cellulose 
Fish oil/ 
Pectin 
Non-irradiated 4.34
a  
± 0.90 
3.23a  
± 0.90 
3.47a  
± 0.90 
4.09a  
± 0.90 
Irradiated 4.42
ab  
± 0.82 
6.00a*  
± 0.82 
2.89b  
± 0.82 
5.01a  
± 0.82 
In each row, means not sharing a common superscript are significantly different 
(p<0.04).  In each column, means with a * are significantly different than other means in 
the column (p<0.02). 
 
 
 
Table A5 
48-hour food intake (g) 
Radiation effects 
 Non-irradiated Irradiated 
Intake 36.94
a  
± 0.39 
39.09b  
± 0.37 
Means not sharing a common superscript are significantly different (p<0.0001). 
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APPENDIX B 
 
EXPERIMENTAL PROTOCOLS 
 
Preparation of a Modified AIN-76A Diet 
15% fat, 6% fiber 
 
Equipment and Supplies: 
 
1. The following ingredients are stored in Room 001L: 
Dextrose Cellulose 
Casein  Mineral Mix 
Pectin 
   
2. The following ingredients are stored in Dr. Lupton’s or Dr. Chapkin’s lab at 
room temperature: 
DL-methionine 
Choline Bitartrate (with desiccant) 
 
3. The following ingredients are stored in a 4°C refrigerator in Dr. Lupton’s or Dr. 
Chapkin’s lab: 
Vitamin Mix Tenox GT-1 (tocopherols) 
Vitamin E Corn oil (under N2) 
 Tenox 20A (TBHQ) 
 
4. The following ingredients are stored in the -20°C walk-in cooler in Dr. Chapkin’s 
lab: 
Fish oil (under N2) 
**REMEMBER TO REMOVE THE OIL EARLY AND ALLOW TO THAW 
 
5. The two mixing bowls and beaters for the Hobart mixer can be obtained from Dr. 
Lupton’s lab, and should be color coded with tape: yellow and orange for corn oil 
diets and green and blue for fish oil diets.  The top loading scale from Dr. 
Lupton’s lab can be carried downstairs and used to measure smaller quantities of 
nutrients.  For larger quantities the large scale in Dr. Chapkin’s lab may be used.  
All ingredients (except the oils) are weighed in the basement where the mixing 
will occur. 
 
6. Obtain 50 1-2 gallon Ziploc plastic bags (12 bags for each diet, 1kg of diet per 
bag).  Write the diet on each bag with a Sharpie and use a piece of colored tape 
for color-coding.  Yellow=Corn/Cellulose;  Orange=Corn/Pectin;  
Green=Fish/Cellulose;  Blue=Fish/Pectin. 
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7. Supplies to bring to the basement: 
2 large mixing bowls and beaters (color coded) for the Hobart mixer 
1 top loading scale 
1 large scale 
12 large plastic containers with lids 
20 small plastic containers with lids 
50 Ziploc bags (1-2 gallon) 
4 spatulas (2 color coded for corn oil & fish oil diets) 
1 large metal spoon 
several scoops (at least one metal) 
several weigh spatulas (large) 
colored tape (yellow, orange, green, blue) 
paper towels, scissors, gloves, and sharpies 
 
 
Weighing Ingredients: 
 
**Make sure all equipment is clean before use. 
Weigh out the ingredients to prepare each diet (12kg/diet). 
 
Dr. Chapkin’s lab: 
Bring 4 extra large beakers (4000 ml), 2 medium beakers (1000 ml), vitamin E, 
Tenox GT-1, Tenox 20A and 4-5 long sterile pipets. 
  
1. Before the large scale is moved, weigh out the amount of oil needed for each 
diet in separate beakers (extra large beakers-2 for corn oil & 2 for fish oil, 
medium beakers-corn oil for fish oil diet). 
 
2. After weighing, add the small amount of corn oil needed for the fish oil diets 
to the fish oil.   
 
3. There should now be four beakers with the appropriate weight of oils for each 
diet.  Place one of the four beakers on the large scale and tare.  Add vitamin E 
5-67, Tenox GT-1, and Tenox 20A directly to the oil until the appropriate 
weight is achieved.  Repeat this for the other beakers of oil. 
 
4. Using a large sterile pipet (one for each oil), stir the oils for about one minute 
or until mixed well. 
 
5. Keep the oils in a tightly covered container and on ice during the transfer to 
the basement and until they are ready to be added to the diet mixture. 
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6. Flush original stock containers of oil with nitrogen and return them to the 
refrigerator or freezer. 
 
To the Basement: 
  Bring equipment listed in #5 of equipment and supplies. 
  Refer to tables attached for weights. 
  
1. Place one of the large plastic containers on the large scale and tare.  Using the 
plastic scoop, add dextrose to the container until the appropriate weight is 
reached.  Remove from the scale, set aside and keep covered.  Repeat this 
procedure until there are four separate containers of dextrose (one for each 
diet).  **If there are not enough containers, weigh out ingredients for only 
one diet.  After mixing, wipe out the containers and reuse for other diets. 
 
2. Using the same procedure as above, weigh out casein and fiber (cellulose or 
pectin) for each diet. 
 
3. Place a small plastic container on the top loading scale and tare.  Using a 
weigh spatula, add mineral mix to the container until the appropriate weight 
is reached.  Remove from the scale, set aside and keep covered.  Repeat this 
procedure until there are four separate containers of mineral mix (one for 
each diet). 
 
4. Using the same procedure as in #3, weigh out vitamin mix, DL-methionine, 
and choline bitartrate. 
 
 
Mixing the Ingredients: 
 **IMPORTANT—PREPARE THE CORN OIL DIETS FIRST 
 
1. Place the large container of casein on a stable surface.  Add the following 
pre-weighed ingredients to the casein in the order listed, stirring briefly 
between each addition with the metal scoop. 
 
DL-methionine 
Choline bitartrate 
Vitamin Mix 
Mineral Mix 
 
Mix the above ingredients well, making sure to get rid of clumps (mineral 
mix tends to clump) 
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2. Using the large bowl for the Hobart mixer (not attached to the mixer yet), 
slowly pour in one of the containers of pre-weighed fiber (cellulose or 
pectin).   
 
3. On top of the fiber, slowly pour in one of the containers of pre-weighed 
dextrose.  Using clean gloves and the metal scoop, mix these two ingredients 
until fairly well blended. 
 
4. On top of the dextrose/fiber mixture, slowly pour in the container of casein 
(mixed with smaller ingredients).  Mix again with metal scoop until fairly 
well blended. 
 
5. Make sure the Hobart mixer is clean and dust free. 
 
6. Place the mixing bowl on the stand and latch it down on both sides.  Attach 
the color-coded mixing beater, and raise the mixing stand until it is at its 
highest point. 
 
7. Set the mixer speed to (1), the slowest speed.  Set the timer for 2 minutes and 
press the start button.  The machine will begin mixing. 
 
8. After 2 minutes, check the bottom of the bowl to ensure that all the 
ingredients are well mixed.  If not use the scoop to reach the bottom and stir 
slightly.  Turn on the mixer again for 1 minute or until the ingredients are 
well mixed. 
 
9. Obtain the appropriate oil for the diet being mixed.  With the mixer speed 
still on (1), press the start button.  Slowly pour about 1/5 of the oil into the 
dry ingredients staying in the area between the beater and the side of the 
bowl.   It may be easier to stop and start the mixer for each addition to avoid 
pouring oil on the beater. 
 
10. Once the oil initially poured appears to be well blended, add another 1/5 of 
the oil mixture and allow it to mix.  Repeat this step until all of the oil 
mixture has been added. 
 
11. Set the timer for 5 minutes and allow the mixer to blend on low speed (1). 
 
12. After five minutes, use clean gloves and a color-coded spatula to clean the 
beater bar and the sides of the mixing bowl.  Try to get as much of the 
mixture off of the spatula as possible. 
 
13. Increase the mixer speed to (2), and blend for another 10 minutes to assure 
complete mixing. 
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14. After storing the prepared diet and cleaning, follow these same steps to 
prepare the other 3 diets. 
 
Storage of Diets: 
 
1. Remove the bowl from the mixer, being sure to scrape as much off of the 
beater bar as possible. 
 
2. Using a clean plastic scoop, place a small amount of the diet mixture into a 
small ziploc bag labeled with the diet and date.  This will be kept on ice and 
returned to Dr. Chapkin’s  lab for analysis.   
 
3. Scoop the diet into the color-coded storage bags.  Using the large scale, place 
approximately 1 kg in each bag and seal (remove as much air from the bag as 
possible). 
 
4. Place the bags of diet in a box and store in Dr. Chapkin’s –80°C walk-in 
freezer. 
 
Clean-up: 
 
1. Clean the large bowl and beater before making the next diet. **Remember to 
use a separate bowl and beater for the corn oil and fish oil diets. 
 
2. Use detergent and the large sink in the equipment room to wash the large 
bowls.  Make sure they are thoroughly clean.  They can be sprayed with 70% 
ethanol and dried with a paper towel between each diet preparation. The 
smaller equipment can be washed there or in the lab. 
 
3. Leftover dry ingredients should be closed and sealed in the box.  Date the box 
for future reference and return it to Room 001L. 
 
4. Date and seal other ingredients used and return them to their original 
locations (i.e. refrigerator, freezer). 
 
5. Sweep and mop the floor of the equipment room. 
 
6. Return all equipment to the appropriate place. 
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Ingredients for 12kg of 
Corn Oil/Cellulose Diet 
 
Ingredients Weight in grams 
Dextrose1 6127 
Casein2 2682 
Cellulose4 720 
Mineral mix5 469 
Vitamin mix6 134 
DL-methionine7 41 
Choline bitartrate8 26 
Tenox GT-19 3.6 
Tenox 20A10 1.4 
Corn Oil11 1800 
Vitamin E12 0 
 
Ingredients for 12kg of 
Corn Oil/Pectin Diet 
 
Ingredients Weight in grams 
Dextrose 6127 
Casein 2682 
Pectin3 720 
Mineral mix 469 
Vitamin mix 134 
DL-methionine 41 
Choline bitartrate 26 
Tenox GT-1 3.6 
Tenox 20A 1.4 
Corn Oil 1800 
Vitamin E 0 
1 Bio-Serv 3400; technical grade 
2 Bio-Serv 1100V; vitamin free 
3 Danisco GRINDSTED Pectin 1100; from citrus peel 
4 Bio-Serv 3425 
5 Bio-Serv F8505; AIN-76A rodent diet 
6 Harlan 40077; AIN-76A rodent diet 
7 Bio-Serv 1340 
8 Harlan 30190 
9 ADM; 80mg/g D-α-tocopherol, 528mg/g total tocopherol 
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Ingredients for 12kg of 
Fish Oil/Cellulose Diet 
 
Ingredients Weight in grams 
Dextrose 6127 
Casein 2682 
Cellulose 720 
Mineral mix 469 
Vitamin mix 134 
DL-methionine 41 
Choline bitartrate 26 
Tenox GT-1 0.81 
Tenox 20A 0.35 
Fish Oil13 1380 
Corn Oil 420 
Vitamin E 0.33 
 
 
Ingredients for 12kg of  
Fish Oil/Pectin Diet 
 
Ingredients Weight in grams 
Dextrose 6127 
Casein 2682 
Pectin 720 
Mineral mix 469 
Vitamin mix 134 
DL-methionine 41 
Choline bitartrate 26 
Tenox GT-1 0.81 
Tenox 20A 0.35 
Fish Oil 1380 
Corn Oil 420 
Vitamin E 0.33 
10 ADM; 20% tert-butyl hydroquinone(TBHQ) 
11 Traco Labs (provided by Sid Tracy) 
12 ADM 410217; vit E 5-67,  672 mg α-tocopherol/gram 
13  Menhaden oil; vacuum deodorized; provided by NIH 
      Fish Oil Test Material Program 
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Isolation of Intestinal Cells for ROS test 
 
 
Preparation-Several days before: 
 
1. Prepare and aliquot stock solutions of BSA (10%), Glutamine (200X), 
Butyrate (200X) and EDTA (50X).  Store EDTA at 4°C.  Store BSA, 
Glutamine and Butyrate at -80°C. 
BSA: 100 X=10 g BSA / 100 ml HBSS-CaMg 
Gln: purchased from GibcoBRL at 200 mM (200 X) 
Butyrate: 200 X=2.2 g Butyrate / 100 ml HBSS-CaMg 
EDTA: 50 X=56 g EDTA / 100 ml HBSS-CaMg 
  
2. Prepare RNase-free PBS, 70% ethanol, 50% ethanol, methacarn, and 4% 
paraformaldehyde. 
**See attached precautions to ensure RNase-free environment. 
PBS (for 4% paraformaldehyde): 
Mix 1 vial of Dulbecco’s Phosphate Buffered Saline (w/o CaMg) into 990 ml 
RNase-free water until dissolved.  Store at room temperature. 
This will make 10X PBS. 
Dissolve 20 ml of 10X PBS into 80 ml of RNase-free water to make 2X PBS. 
70% and 50% ethanol: 
1400 mL 100% ethanol + 600 mL RNase-free water = 2 liters of 70% ethanol 
Make 1.2 L / rat 
1000 mL 100% ethanol + 1000 mL RNase-free water = 2 liters of 50% 
ethanol 
Make 1 L / rat 
4% paraformaldehyde: 
**Do not breathe paraformaldehyde.  Wear mask when weighing and 
perform other steps in a hood.  Paraformaldehyde must be prepared fresh 
every week (100 mL/rat). 
Add 24 g of PFA to 300 mL RNase-free water. 
Stir and heat gently to 60°C (setting 2 on hot plate in Chapkin lab) for 5 
minutes. 
Solution will be cloudy. Add 6-30 drops of 1 M NaOH until solution clears. 
Let cool. 
Add 300 mL 2X RNase-free PBS. 
Store at 4°C for up to 1 week. 
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Preparation-Day before: 
 
1. Bake necessary equipment @ 180°C: 
50ml flasks (for shaking incubation) (1 / tissue) 
1000ml bottle (for PBS) 
1000ml bottles or flasks (for HBSS solutions) 
large magnetic stir bars (1 / HBSS solution) 
spatulas 
large glass graduated cylinders (for measuring HBSS & PBS) 
 
2. Autoclave and RNase-zap rubber policeman for scraping tissue (1 / tissue). 
 
3. Prepare 1X PBS if necessary 
Mix 1 vial of Dulbecco’s Phosphate Buffered Saline (w/o CaMg) into 990 ml 
RNase-free H2O until dissolved.  Store at room temperature. 
This will make 10X PBS. 
Dissolve 100 ml of 10X PBS into 900 ml of RNase-free H2O to make 1X 
PBS. 
 
4. Set out equipment listed above and pre-labeled instruments and supplies: 
Surgical equipment (blunt and sharp scissors, forceps) 
50ml centrifuge tubes  labeled RNase-free cassettes  
petri dishes   25ml sterile pipets 
pipet tips    sterile transfer pipets 
2 well chamber slides  18x18 cover slips 
50ml test tube racks  gauze pads 
large and small weigh boats biohazard bags 
specimen cups 
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Preparation-Day of Experiment 
 
1. Arrive approximately 2 hours before scheduled time of kill.  Turn on shaking 
water bath and bench top water bath.  Warm to 37°C. 
 
2. Remove BSA and Glutamine aliquots from -20°C freezer and Butyrate 
aliquots from -80°C freezer.  Allow to thaw at room temperature. 
 
3. Measure out amounts of buffers needed for procedure: 
1000ml 1X PBS 
980 ml HBSS+CaMg  (1000 after additives)—generally 5 ml/cm tissue 
480ml HBSS-CaMg   (500 after additives)—generally 5 ml/cm tissue 
Warm solutions to 37°C in water bath and bubble with 95%O2/5%CO2 for 30 
minutes.  Solutions will remain at 37°C for the remainder of the procedure. 
 
4. Prepare H2O2 and DPI solutions. 
H2O2: 
0.57 mL 30% H2O2 + 4.43 mL ddH2O = 1 M H2O2
0.25 mL of 1 M H2O2 + 4.75 mL ddH2O = 50 mM H2O2 (wrap tube with foil) 
DPI: 
15.9 mg DPI + 10 mL ddH2O = 5 mM DPI 
 
5. After solutions are bubbled, add the previously prepared stock solutions to 
the appropriate buffer solution as described in the table below.  Use RNase-
free stir bars and spatulas. 
 
Amount to add in ml Amount to add in mg  
EDTA 
50X 
Glutamine 
200X 
Butyrate 
200X 
BSA 
10% (100X) 
DTT 
(add as powder) 
HBSS+CaMg 
(1000ml) -- 5 5 10 -- 
HBSS-CaMg 
(500ml) 10 2.5 2.5 5 385 
Final Conc. 30mM 1mM 1mM 0.1% 5mM 
  
6. Adjust HBSS solutions pH to 7.4. 
 
7. Pour 70% ethanol, methacarn and PFA into specimen cups (put methacarn 
and PFA on ice) for fixations.  **Remember RNase-free. 
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Crypt Isolation Procedure 
**This procedure describes the isolation of all 4 tissues (duodenum, ileum, proximal 
colon and distal colon).  However, only 2 tissues at a time will be isolated. 
 
1. Euthanize rat by CO2 asphyxiation (3 min) and cervical dislocation.  Open 
abdomen with a ventral midline incision and perforate the diaphragm. 
 
2. Cut the large intestine at the rectum.  Cut one centimeter of most distal colon 
for cassetting.  Measure six centimeters and cut again (distal colon).  
Continue to remove the large intestine up to the cecum.  Cut intestine at 
cecum and take one centimeter from most proximal colon for cassetting.  
Measure six centimeters for the proximal colon.  Place each six centimeter 
tissue segment in separate weigh boats of warm PBS. 
 
3. Dispose of cecum.  Cut the next seven centimeters of small intestine (ileum) 
and cut the most distal centimeter for cassetting.  Continue to remove the 
small intestine up to the stomach.  Cut the first six centimeters of small 
intestine (duodenum) and cut the most proximal centimeter for cassetting.  
Place each six centimeter tissue in separate weigh boats of warm PBS. 
 
 
4. Flush duodenum from distal to proximal end with a sterile syringe and warm 
PBS.  Cut open duodenum, ileum, proximal and distal colon to expose lumen 
and rinse in warm PBS.  Place each tissue  in separate 50ml flasks containing 
30ml (5ml/cm of tissue) of HBSS-CaMg+EDTA+DTT buffer.  Incubate in 
the shaking water bath for 15 minutes.  Set the shaker to level #6. 
 
5. After 7-8 minutes of incubation, aspirate the incubation solution of the 
duodenum and place in a 50ml sterile centrifuge tube.  Add another 30ml of 
HBSS-CaMg+EDTA+DTT buffer to the tissue in the flask. Continue the 
incubation for another 7-8 minutes with #6 shaking. 
 
6. Centrifuge the incubation solution from the duodenum at 100xg (800RPM) 
for 3 minutes at room temperature.  Remove supernatant and resuspend in 
30ml HBSS+CaMg to wash cells.  Centrifuge again for 3 minutes, remove 
supernatant and resuspend in 15ml HBSS+CaMg.  Keep the suspension at 
37°C. 
 
7. After the shaking incubations are completed pour the contents of each flask 
into separate sterile petri dishes.  Gently scrape the mucosal side of the tissue 
with a RNase-free rubber policeman.  
 
8. Using a sterile pipet, transfer the contents of the petri dish into a 50ml 
centrifuge tube and place in centrifuge. 
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9. Centrifuge the four cell suspensions at 100xg (800RPM) for 3 minutes at 
room temperature.  Remove supernatant and resuspend in 30ml HBSS+CaMg 
to wash cells.  Centrifuge again for 3 minutes, remove supernatant and 
resuspend duodenum cells in 15ml HBSS+CaMg.  Resuspend the ileum, 
proximal colon and distal colon in 30ml HBSS+CaMg. 
 
10. Combine each 15ml suspension of the duodenum for a total volume of 30ml.  
Keep all cell suspensions at 37°C and take to Image Lab. 
 
 
At the Image Lab 
  
Don’t forget to bring: 
 warm cell suspensions chamber slides 
1.5ml microcentrifuge tubes 18x18 cover slips 
 H2O2    pipet tips and pipets 
 DPI    leftover HBSS+CaMg buffer 
 centrifuge and microcentrifuge tube racks for incubator 
 time sheet 
 extra timers if necessary 
  
 Testing for ROS 
 
1. Hold all cells in 37°C incubator in cell culture room until needed. 
 
2. Add 20 µL of DMSO to vial of CMH2DCFDA (stored in freezer) and pipet 
up and down slowly to mix. 
 
3. Aliquot necessary amount of viability dye, Ethidium Homodimer, (1 µL / 
tube)  into microcentrifuge tube covered with foil. 
 
4. Add 1 ml of HBSS+CaMg buffer and 25 µl of the appropriate cell pellet to 
the labeled microcentrifuge tubes.  (We had duplicate tubes for each 
treatment.) 
 
5. After adding treatment (according to time chart), invert microcentrifuge tubes 
to mix cells and incubate the suspensions for the appropriate time at 37°C.  
Cells will settle to the bottom of the tube. 
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6. Load 1µl of CMH2DCFDA to each eppi tube of cells 15 minutes before the 
completion of the incubation time.  Invert tube to mix cells. 
 
7. When the incubation and loading are complete, transfer 2µl of the cell pellet 
to a 2 well chamber slide.  Gently cover with an 18x18 cover slip (try to 
avoid smashing cells).  Give to Rola for ROS analysis on Meridian Ultima. 
 
8. After Rola has completed her analysis of a treatment, load 1 µL of Ethidium 
Homodimer to the cells remaining in the tube, invert tube and incubate at 
37°C for 5 minutes. 
 
9. After incubation with the viability dye is completed, transfer 2 µL of the cell 
pellet to a glass microscope slide.  Cover with and 18x18 cover slip.  At the 
Scanalytics microscope, place a drop of oil on the lens and place the 
microscope slide upside down on the stage.  Using UV, select 10 different 
frames of cells and estimate the percentage that are green (viable).  Red cells 
are not viable. 
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Apoptosis - ApopTag Kit 
 
Note:  To be performed on 4%PFA fixed tissue. 
 
reagent  company          catalog # 
Apotag Kit:  Chemicon    S7101 
Proteinase K  Ambion   2546 
PBS   Life Technologies  21600-069  
 
***Put 200 ml PBS for Prot. K in 37° C oven and begin bleach rinse. 
 
1.  Deparaffinize and rehydrate tissue: 
 Xylene, 3X, 5 min 
        let xylene just dry, circle sections w/ PAP pen, dry 1 min 
 100% EtOH, 2X, 5 min 
 95% EtOH, 1X, 3 min 
 70% EtOH, 1X, 3 min 
 PBS, 1X, 5 min 
(Get Equilibration Buffer and Reaction Buffer out of freezer-put on ice) 
 
2.  Pretreat tissue – 3 min, in 37° 
 Proteinase K (10 µg/ml PBS)  = 0.1 ml Proteinase K (Ambion # 2546) in 
200 ml PBS. 
 
3.  Wash in dH2O, 2x, 2 min 
 
4.  Quench Endogenous Peroxidase: 0.3% H2O2 in 100% Methanol: 
3.0 ml 30% H2O2 in 297 ml 100% Methanol or 2.0 ml in 198 ml(add fresh H2O2 
immediately before quenching).  30 min, RT 
 
5.  Wash in dH2O, 2x, 5 min 
  
6.  Wash all slides in PBS 5 min. 
 
7.  Gently tap off PBS and carefully blot around sections.  (Do this step and following 
step one slide at a time to avoid drying out sections.) 
 
8.  Apply EQUILIBRATION BUFFER to all sections:  incubate in humidified chamber 
for 15 sec to 1 hr @ RT. 
 (# of slides X 150 µl) (9 slides X 150µl = 1.35 ml) 
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9.  Tap off equilibration buffer and immediately apply REACTION BUFFER (- 
controls) or working strength TdT Enzyme with dilution ratio 1/30 (enzyme 
/reaction buffer).  (Get TdT directly from freezer & keep on ice) 
 
Apply only reaction buffer to  – control sections: 
___(# sections) X 40µl 
 
For normal sample sections (# sections X 40µl): 
1080 µl  reaction buffer (for 9 slides) 
36 µl TdT enzyme (for 9 slides) 
 
Incubate in a humidified chamber at 37°C, 1 hr 
(Prepare Stop/Wash so it can warm to RT.) 
 
12. Put slides in coplin jar with Working Strength Stop/Wash Buffer (1ml + 34 ml 
dH2O).  Agitate for 15 sec; incubate 10 min, RT. 
Take aliquot of ANTI-DIGOXIGENIN PEROXIDASE (# slides X 125 µl) and 
allow to warm to room temperature (9 slides x 125µl = 1.125ml) 
 
14.  Wash slides in PBS, 3X, 1min 
 
15.  Blot dry the slides quickly (do one slide at a time) and apply ANTI-DIGOXIGENIN 
PEROXIDASE to all sections; incubate 30 min. in humidity chamber @ RT. 
 
16.  Wash in PBS 4X, 2min 
Prepare DAB peroxidase (1:50, substrate:dilution buffer) (#slides x 150µl) and 
warm to room temperature.  Protect from light. (9 slides X 150µl = 1350µl = 
27µl substrate:1323µl dilution buffer) 
 
17.  Blot dry the slides quickly (do one slide at a time) and stain sections with DAB until 
light brown color shows up  (< 1 min). 
 
18.  Wash in dH2O, 3X, 1 min  
 Leave in 4th  for 5 min 
 
19. Counterstain w/ Methyl Green (reusable): 
 Dip quickly into Methyl green 
 Rinse in dH2O 5X; dip 1x in the 1st 2 changes and briefly agitate 
Dip 10 x in 3rd & leave ~ 30 sec. 
Leave in the last 2 for 1 min w/o agitation 
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20.Dehydrate: ALL FRESH 
70% EtOH, 1X, 1 min 
95% EtOH, 1X, 1 min 
100% EtOH, 1X, 1 min 
Xylene: 3X, 2 min  (dip 10 times/ea) 
 
21. Wet mount w/ Permount (80:20, Permount:Xylene) – leave overnight to dry 
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Apoptosis Scoring and Quantitation 
 
Selection of crypts and villi 
1.  Examine positive and negative controls from each assay run to ensure the assay 
worked correctly every time. 
 
2.  Beginning with the right side of the slide, read sections from top to bottom. 
 
3.  Use the following criteria to determine scorable crypts: 
a.  base of the crypt must touch or be very near the muscularis layer. 
b.  crypts must be open to the luminal surface. 
c.  crypt height must be easily determined by being able to count the cells on at 
least one side of the crypt as a continuous line. 
 
4.  Use the following criteria to determine scorable villi: 
a.  villi base must be in contact with a crypt (crypt does not have to meet scorable 
crypt criteria) 
b. at least one side of the villi must be completely intact 
NOTE:  if unable to obtain 25 intact villi columns, villi that are missing some 
surface cells but the upper curve is still apparent may be scored 
c.  the top of the crypt and the bottom of the villi must be discernable by the slight 
outward curve on at least one side (the outward curve on the opposite side may be 
used as a reference) 
 
Scoring crypts and villi 
1. Colon crypts which have met the scoring criteria are counted under 40X 
magnification and the following guidelines are used: 
a.  the crypt is divided down the middle with an imaginary line and the cells 
along one or both sides of the crypt are counted (this is called the crypt 
column);  cell number 1 is the first complete cell to the side of the imaginary 
line 
b.  if an apoptotic cell is present, it is marked on the scoring sheet according to its 
location (see attached scoring sheet) 
c.  cells are only counted to the point where the crypt begins to curve out 
d.  if desired, 3-5 surface cells immediately following the top cell of the crypt 
may be scored (ensure that these cells are not beginning to curve into the 
neighboring crypt) 
e.  if both sides of the crypt are counted, note this on the scoring sheet 
f.  a total of 20-25 crypt columns/tissue are scored 
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2.  Small intestine crypts are also counted under 20X or 40X magnification by the 
same method as the colon crypts.  The only exception is that there are no surface 
cells since the location where the crypt curves out is the beginning of the villi. 
 
3.  Small intestine villi that have met the scoring criteria are viewed under 20X 
magnification and an image of the villi is captured using NIH image. 
a.  if the crypt leading to the villi was also scored, type the crypt number (from 
scoring sheet) over the crypt in the image and save;  also mark on the crypt scoring 
sheet that the villi attached to that crypt was scored 
b.  when saving images, use a numbering system that ensures you will score the 
villi in the order that they were seen on the slide (left to right, top to bottom) 
NOTE:  This means that villi images must be captured at the same time crypts 
are being scored!!  The crypt is scored immediately and the image of the villi is 
taken for scoring at a later time. 
 
4.  After images are collected, villi are scored in NIH image using the following 
guidelines: 
a.  divide the villi longitudinally down the center with an imaginary line as was 
done with the crypt and one or both of the sides (columns) will be used to 
determine villi height 
b.  to measure the height of a villi column, pixels must be converted to microns 
(see additional instructions below) 
c.  using the measuring line in NIH image toolbox, draw a line from the top of 
the villi to the crypt top (segmented line may be used to accommodate for 
curves in the villi); if some of the villi surface cells are missing, begin the line 
where the first cell in the column appears (this will be considered the top of 
the villi) 
d.  under the “Analyze” pull-down menu, select “Measure” and then select 
“Show Results”  to display the length of the line in microns 
e.  divide the length of the line into thirds and using the line drawing tool, divide 
the villi into tertiles (the measuring line may have to be used again to 
determine the appropriate points at which to divide the villi) 
f.  count the number of apoptotic cells within each tertile and record this on the 
villi scoring sheet (see attached scoring sheet) 
g.  a total of 20-25 villi columns/tissue are captured and scored 
 
Calculations 
Apoptotic Index is used to normalize the number of apoptotic cells in a crypt column to 
the number of cells actually in a crypt column. 
 
1.  Apoptotic index for crypts: 
 a.  for each crypt column 
the number of apoptotic cells in a crypt column
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the total number of cells in a crypt column 
b. for a tissue or rat 
average of apoptotic indices for crypt columns 
2.  Apoptotic index for surface cells: 
 a.  for each crypt column 
the number of apoptotic cells scored on the surface 
 the total number of scored surface cells 
 b.  for a tissue or rat 
average of apoptotic indices for surface cells 
3.  Apoptotic index for villi: 
 a.  for each villi column 
number of apoptotic cells in a villi column 
height of villi in microns 
 b.  for a tissue or rat 
average of apoptotic indices for villi columns 
 
NOTE:  DO NOT calculate the rat or tissue apoptotic index with the following equation: 
 (Total number of apoptotic cells/total number of crypt columns) 
  average crypt ht 
 where the "average crypt ht" = total number of cells in a crypt column
      total number of crypt columns 
 
 
 
Additional instructions: 
 Measuring in microns 
1. use a stage micrometer to determine the number of pixels in a micrometer (be 
sure to use the correct magnification) 
10X 1µm = 0.5 pixels 
20X 1µm = 1 pixel 
40X 1µm = 2 pixels 
2. in NIH image, under the “Analyze” pull-down menu, select “Set Scale” 
3. change the units to microns and set how many pixels are in a micron 
4. step 3 needs to be done every time you open NIH image as it will reset back 
to pixels after it is closed 
 
Other general information: 
¾ These instructions are for NIH image software.  Metamorph can also be used but the 
instructions will differ. 
¾ The average time needed to completely score one colon slide is 1 hour. 
¾ The average time to completely score one small intestine slide (crypts and villi) is 2-
1/2 hours. 
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Preparation of cells for protein and antioxidant enzyme assays 
 
Background:  Cells were prepared using protocol for isolation of intact crypts.  Cells 
were spun down in HBSS+Ca/Mg and the supernatant removed.  Cells were frozen at –
80. 
 
Equipment: 
pH meter (calibrated) 
Microcentrifuge (4°C) 
Sonicator (Chapkin Lab) 
 
Reagents: 
K2HPO4   Sigma 
KH2PO4   Sigma 
Sucrose   Sigma S7903 
EDTA (disodium) 
Protease Inhibitor Cocktail Sigma  P8340 
Triton X-100   Calbiochem 648464 
Dithiothreitol (DTT)  Sigma D9779 
 
Preparation of homogenization buffer (adapted from Dr. Wu’s assay for enzyme 
extraction) 
1. Prepare 50mM Potassium Phosphate buffer 
--50mM K2HPO4:  Dissolve 4.35g of K2HPO4 in 500ml of deionized H2O 
--50mM KH2PO4:  Dissolve 3.4g of KH2PO4 in 500ml of deionized H2O (use 1L 
bottle) 
--50mM potassium phosphate buffer (pH 7.2): Add 50mM K2HPO4 to 50mM 
KH2PO4 until pH is 7.2 
2. Prepare 250mM Sucrose/1mM EDTA solution by dissolving 42.8g of sucrose 
and 186mg of disodium EDTA in 500ml of potassium phosphate buffer.  pH 
again to 7.2 (use KOH or HCl) 
 
3. Prepare homogenization buffer (250mM sucrose/1mM EDTA/1mM DTT in 
50mM potassium phosphate buffer):   
5ml - 250mM sucrose/1mM EDTA solution 
200µl – protease inhibitor cocktail 
5µl – Triton X-100 (0.1%) 
5µl – 1M DTT solution (made fresh) 
0.3858 mg DTT in 2.5mL Phosphate Buffer 
***Homogenization buffer should be prepared fresh each day.*** 
 
 
 115
Cell homogenization 
1. Thaw cell pellet in appropriate amount of homogenization buffer.  Aspirate cell 
pellet through 27 gauge needle several times.  Sonicate cells briefly (2-3 seconds) 
at 20-second intervals for about 1 minute (distal colon may need >1minute). 
4-5cm Distal colon - 150µl 
4cm Duodenum – 200 µl 
8cm Duodenum – 350 µl 
2. Transfer crypt suspension to microcentrifuge tube. 
3. Centrifuge cells for 3 minutes @ 10000 x g (4°C). 
4. Transfer supernatant to clean microcentrifuge tube.  (Pellet may be discarded or 
examined with Trypan Blue to determine efficiency of lysis process.) 
5. Supernatant can be aliquoted appropriately for assays: 
a. 10µl for protein 
b. remainder for antioxidant enzyme assays 
6. Aliquots of homogenization buffer will need to be saved for protein assay and 
aliquots may be needed for dilution of samples for assays. 
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Coomassie Protein Assay 
 
Equipment: 
Microtiter plate reader (A595) 
 
Reagents: 
Coomassie Plus Protein Assay Kit Pierce 23236 
 contains Coomassie Blue stain 
     BSA standards (2mg/ml) 
 
Procedure: 
1. Prepare BSA standards: 
2µg/µl (in kit) 
500µl of 2µg/µl + 500µl ddH2O = 1µg/µl 
125µl of 2µg/µl + 1000µl ddH2O = 0.25µg/µl 
(this is sufficient for only one set of standards) 
2. Prepare microcentrifuge tubes of standards and samples in triplicate.  (Add 
Coomassie to all tubes last.) 
 
Standards: 
µg 
protein 
0.25µg/µl 
BSA 
1µg/µl 
BSA 
2µg/µl 
BSA 
Water Homog. 
Buffer 
Coomassie 
Reagent 
0 0µl - - 497.5µl 2.5µl 500µl 
1 4µl - - 493.5µl   
2 - 2µl - 495.5µl   
4 - 4µl - 493.5µl   
10 - 10µl - 487.5µl   
20 - - 10µl 487.5µl   
   
 Samples: 
Amt. of 
sample 
Water Coomassie 
Reagent 
2.5µl 497.5µl 500µl 
 
3. Incubate samples in Coomassie at RT for 10 minutes. 
4. Transfer 300µl of each tube to the appropriate well on a microtiter plate. 
5. Read absorbance (A595) on microtiter plate reader. 
(Absorbances for standards generally range from 0.3 to 1.0.) 
6. Plot standard curve (absorbance vs. µg protein).  Most plate readers will do this 
for you. 
7. Use readout of “unknowns” to determine protein concentration of samples. 
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Antioxidant Enzyme Assays 
Catalase, Glutathione Peroxidase and Superoxide Dismutase 
 
Background:  Protein was determined by Pierce Coomassie Assay. 
 
Equipment: 
Microtiter plate reader (Bio-Tek) 
Microtiter plates (Fisher, flat bottomed, 360ul) 
 
Reagents: 
Catalase Assay Kit  Calbiochem 219263 
Glutathione Peroxidase Kit Calbiochem 354104 
Superoxide Dismutase Kit Calbiochem 574600 
Superoxide Dismutase Calbiochem 574594 
Sodium Azide (NaN3)  Sigma S8032 
30% H2O2   Sigma H1009 
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Catalase 
Based on kit instructions. Protein levels must be determined prior to assay (Coomassie 
Blue.) 
 
Prepare CAT standard and dilutions: 
1. Add appropriate amount of deionized water to Standard vial (volume 
recommended on vial or by tech support – generally 1.1 ml) 
2. Prepare dilution aliquots by combining the indicated volumes of standard as 
described in the table below. 
Standard, µL 0 26.4 56.8 133.6 240 400 
Sample Diluent, µL 400 400 400 400 400 400 
Final Activity, U/mL 0 10 20 40 60 80 
 Freeze 25µL aliquots at –20°C.  Stable for 1 month. 
 
Prepare Reagents: 
1. Add 1 volume of HRP to 1000 volumes of Chromogen reagent.  Stable for one 
month if stored sealed and protected from light at 4°C.  If reagent develops a 
slight pink color it has deteriorated and must be replaced. 
2. Add 1 volume of 30% H2O2 to 1000 volumes of Substrate diluent.  Stable for one 
week if store sealed and protected from light at 4°C. 
***Reagents must be brought to room temperature before use.*** 
 
Prepare microplate reader (Lupton Lab – BioTek) by opening protocol and preparing for 
read.  Allow reader to calibrate before use.  Only do, at the most, 6 samples (in triplicate) 
at one time. 
 
Assay: 
1. Dilute samples with homogenization buffer according to protein content (approx 
3µg/µL). 
2. Prepare triplicate 1.7ml microcentrifuge tubes and add 3µL of the following: 
a. 0 U CAT std (Sample diluent) 
b. 10 U CAT std 
c. 20 U CAT std 
d. 40 U CAT std 
e. 60 U CAT std 
f. 80 U CAT std 
g. Sample 
3. Add 3µL of protein buffer to standard tubes.  Add 3µL of sample diluent to 
sample tubes. 
4.  Add 50µL of 10mM H2O2 to each tube and incubate at RT for 1 min. (Can do 18 
tubes during this minute.  Have Stop Reagent ready immediately.) 
5. Add 50µL of Stop Reagent.  Mix well but do not vortex. 
6. Add 3µL of reaction mixture to wells. 
 
 119
7. Add 300µL of HRP/Chromogen Reagent to microplate wells.  Mix well. 
8. Incubate in the dark at RT for 10 minutes. 
9. Read absorbance at 520nm. 
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Glutathione Peroxidase 
Based on kit protocol with modifications - use NaN3 and H2O2 instead of tert-butyl 
hydroperoxide.1  
 
Prepare Reagents: 
1. Add 7.5mL of assay buffer to vial of NADPH.  Mix well.  Keep on ice or 
refrigerated and protected from light.  Reagent is only good for 24 hours. Do not 
refreeze. 
2. Prepare 700µM H2O2.  Add 1.134mL of 30%H2O2 to 8.866mL H2O to make 1M 
H2O2.  Add 7µL of 1M H2O2 to 9.993mL H2O to make 700µM H2O2.  Store at 
4°C and protect from light.  Stable for 1 week.  
3. Add 0.325g of NaN3 to 5mL of phosphate buffer to make 100mM NaN3.  Aliquot 
if needed and keep refrigerated until use. 
***All reagents must be brought to RT before use.*** 
 
Prepare microplate reader by opening protocol and preparing for read.  Allow reader to 
calibrate before use. 
 
Assay: 
1. Dilute samples with homogenization buffer according to protein content 
(>7µg/µL pro). 
2. Prepare triplicate microplate wells of each column by adding the following 
reagents in the order listed: 
Assay Buffer, µL 75 75 
NADPH, µL 75 75 
NaN3, µL 2.4 2.4
Sample, µL -- 15 
Buffer, µL 15 -- 
 
3. Place plate in tray of the reader.  Add 75µL of 700µM H2O2, mix well on plate 
reader plate shaker (intensity 2 for 15 seconds) and read absorbance at 340nm as 
often as possible for three minutes. 
 
                                                 
1 Tert-butyl hydroperoxide is a substrate for some glutathione S-transferases.  Therefore, H2O2 is the 
preferred substrate in cell lysates and tissue homogenates.  However, catalase must also be inhibited which 
is accomplished by the addition of 1mM sodium azide (NaN3) (Flohe and Gunzler, Methods in 
Enzymology, 1984).  
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Superoxide Dismutase 
Based on kit protocol. 
 
***All reagents and microplate reader must be at 37°C before use.*** 
 
Prepare microplate reader by opening the protocol entering the template and setup. 
 
Assay: 
1. Dilute samples with homogenization buffer according to protein content 
(>6µg/µL). 
2. Prepare triplicate microplate wells by adding the following reagents in the order 
listed: 
 
Buffer, µL 225
Sample, µL 10 
R2, µL 7.5 
 
3. Mix well after addition of R2 and incubate samples for at least 1 minute at 37°C. 
4. Add 7.5µL of R1 and mix well. (Have computer ready to read and plate sitting in 
reader tray.) 
5. Immediately read absorbance at 525nm as frequently as possible for 3 minutes.  
 
***Helpful tip:  Put R1 reagent in wells of an empty plate – draw it out with a multi-
tip pipettor and add to samples.*** 
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Immunohistochemistry of 8-hydroxy-2’-deoxyguanosine 
 
Note:  For 70%EtOH fixed tissue. 
 
Day 1 
 
___1. Deparaffinize slides and rehydrate tissue: 
 ___3 x 5 min Xylene 
 ___Let slide just dry, circle sections with PAP pen, dry 1 min 
 ___2 x 2 min 100 % ETOH 
 ___2 x 2 min 95 % ETOH 
 ___1 x 2 min 70 % ETOH 
 ___1 x 5 min H2O 
 
___2. Wash in TBS for 2 min x 2.  Gently tap off TBS and blot around sections.  (Do 
this step and following step one slide at a time to avoid drying out sections.) 
 (Prepare RNase dilution.) 
 
___3. Treat sections with RNase (100 µg/ml Tris buffer) for 1 h at 37 °C in humidity 
chamber. 
(Tris buffer recipe and RNase prep listed on separate sheet.) 
 
___4. Wash in TBS for 2 min x 3. 
 
___7. Denature DNA by placing slides in 4 N HCl for 7 min at RT. 
(HCl recipe on separate page.) 
 
___8. Neutralize with 50 mM Tris base for 5 min at RT. 
(Tris base recipe on separate page.) 
 
___9. Wash in TBS for 5 min x 2.  Gently tap off TBS and blot around sections.  (Do 
this step and following step one slide at a time to avoid drying out sections.) 
 (Prepare 10% serum.) 
 
___10. Incubate sections with 10% rabbit serum (Jackson #011-000-120) in TBS 1 h 
at RT in humidity chamber.  
 (Prepare primary Ab dilution.) 
 
___11. Incubate sections with primary Ab (1:20 in TBS w/ 1% rabbit serum (50mM 
Tris)) (Oxis #24325) at 4 °C in humidity chamber overnight.  (Recipe for TBS 
with 50mM Tris on separate page.) 
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Day 2 
 
___12. Wash in TBS for 5 min x 3.  Gently tap off TBS and blot around sections.  (Do 
this step and following step one slide at a time to avoid drying out sections.) 
 (Prepare secondary ab dilution.) 
 
___13. Incubate sections with biotinylated rabbit anti-mouse (1:800 in TBS w/ 1% 
rabbit serum (remember already diluted 1:1 in glycerol)) (Jackson #315-065-045) 
45 min at RT in humidity chamber.  
  
___14. Wash in TBS for 5 min x 3. 
 
___15. Apply 3% H2O2 (Sigma #H-1009) in methanol for 30 min to quench 
endogenous peroxidase. 
 (Add 1ml H2O2 for every 10 ml of methanol.  Add H2O2 immediately before 
quenching.) 
 (Prepare ABC-HRP and let stand for 30 min.) 
 
___16. Wash in TBS for 5 min x 3.  Gently tap off TBS and blot around sections.  (Do 
this step and following step one slide at a time to avoid drying out sections.) 
 
___17. Incubate with ABC-HRP kit (Vector #PK-6100) for 1 h at RT in humidity 
chamber.  
1) 5 ml 1X TBS 
2) Add 2 drops of reagent A and mix well 
3) Add 2 drops of reagent B and mix well 
 
___18. Wash in TBS for 5 min x 3.  Gently tap off TBS and blot around sections.  (Do 
this step and following step one slide at a time to avoid drying out sections.) 
(Prepare DAB and water rinse.) 
 
___19. Apply DAB (Vector #SK-4100) stain for 1 min (or until brown stain shows up).  
Tap off DAB, rinse briefly with ddH2O and place in ddH2O.  Finish one slide 
before moving to next slide. 
1) 5 ml dH2O. 
2) 2 drops of buffer, mix. 
3) 4 drops of DAB, mix. 
4) 2 drops of H2O2, mix. 
 
___20. Wash in ddH2O for 1 min x 2. 
 
___21. Dehydrate slides: 
 1 x 1 min 70 % ETOH.      
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 1 x 1 min 95 % ETOH. 
 1 x 1 min 100 % ETOH. 
 1 x 2 min Xylene. 
 
___22. Mount cover glass with Permount (Fisher #SP15-500). 
 (Permount diluted - 20% xylene, 80% permount.) 
 
 
 
 
Recipes for 8OHdG 
 
TBS (20mM Tris, 0.9% NaCl, pH 7.5) (Sigma) – all washes and dilutions except 
primary ab 
As received: 10X Concentrate 
Dilution: 1X with ddH2O 
 
Adjust pH to 7.5 with HCl.  Prepare as needed. 
 
 
TBS (50mM Tris, 0.9% NaCl, pH 7.5) – for primary ab dilution only 
121.1g/mol x 0.05mol/L = 6.055 g/L Tris base (Sigma #T-1503) 
0.9% NaCl x 1000ml = 9g NaCl (Sigma) 
    1 L ddH2O 
 
Adjust pH to 7.5 with HCl.  Prepare as needed. 
 
 
Tris Buffer (10mM Tris, 1mM EDTA, 0.4M NaCl, pH 7.5) – for RNase dilution 
121.1g/mol x 0.01mol/L = 1.211 g/L Tris base (Sigma #T-1503) 
380.2g/mol x 0.001mol/L = 0.3802 g/L (Sigma # ED4SS) 
58.44g/mol x 0.4mol/L = 23.38 g/L (Sigma #BP358-1) 
    1L ddH2O 
 
Adjust pH to 7.5 with HCl.  Prepare as needed. 
 
 
Tris base (50mM) 
121.1g/mol x 0.05mol/L = 6.055g/L 
    1L ddH2O 
 
Do not pH.  Prepare as needed. 
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RNase (Ambion #2272) 
As received: 1ml [1mg/ml] 
Dilution: 100ug/ml Tris buffer 
 
100ul stock + 900ul Tris buffer = 1ml of 100ug/ml 
 
Remove aliquot on day of assay.  Add Tris buffer to appropriate dilution. 
 
 
4N HCl 
As received: 30M solution 9 (EM Science #HX0603-3) 
Dilution: 4M solution 
 
Normality = molarity x number of H+ released by acid 
4N HCl = 4M HCl 
 
4M/30M = 0.13 
130ml of 30M HCl 
870ml of ddH2O 
 
Prepare as needed. 
 
 
Rabbit Serum (Jackson #011-000-120) 
As received:  Freeze dried 
Reconstitution: Add 5ml ddH2O (100% serum) – good for 6 weeks at 4° 
Dilution:  10% serum – good for 1 day 
 
1ml 100% serum 
9ml TBS 
 
Remove aliquot on day of assay.  Add TBS to appropriate dilution. 
 
 
Primary Antibody (Oxis # 24325) 
As received:  Freeze dried 20 ug vial  100 ug vial 
Reconstitution: 100ug/ml 0.2 ml ddH2O  1ml ddH2O --good 
1month at 4° 
Dilution:  5-10ug/ml with TBS (50mM Tris) 
 
Remove aliquot on day of assay.  Add TBS to appropriate dilution. 
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Secondary Antibody (Rabbit anti-mouse:  Jackson #315-065-045) 
As received:  Freeze dried 
Reconstitution: Add 1ml ddH2O – good for 6 weeks at 4° 
   Add equal portion of glycerol (1ml) – store in -20° 
Dilution:  1:600 in TBS (1:300 if in glycerol) 
 
2ul antibody / 4ul antibody (in glycerol)  
1200ul TBS 
 
Remove aliquot on day of assay.  Add TBS to appropriate dilution. 
 
 
3% H2O2 in methanol 
30% H2O2  (Sigma H-1009) 
100% Methanol 
 
Add 1ml of 30% H2O2 to every 10ml of MeOH for 3% H2O2. 
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Determination of GSH and GSSG 
by high-performance liquid chromatography with fluorescence 
detection of dansyl derivatives 
 
Obtained from Dr. Wu & performed in his lab.  Original protocol from Jones et al.2
 
***Protocol performed on scraped mucosa frozen in liquid nitrogen and stored at -80°C. 
 
Chemicals & supplies needed: 
Name Supplier & Catalog # 
Sodium Heparin Sigma H4784 
Bathophenanthroline disulfonate sodium salt (BPDS) Sigma B1375 
Iodoacetic acid Sigma I2512 
Dansyl chloride Sigma 39220 (Fluka) 
L-serine Sigma S4500 
GSH standard Sigma G6529 
GSSG standard Sigma G6654 
Sodium acetate trihydrate Sigma S9513 
Boric acid Sigma B0394 
Sodium tetraborate Sigma B0127 
70% Perchloric acid Fisher A469 
r-glutamylglutamate (r-glu-glu) Sigma G3640 
HPLC grade water Fisher W7 
Potassium hydroxide (KOH) Sigma P5958 
Potassium tetraborate tetrahydrate Sigma P5754 
Acetone Fisher A949 
Chloroform Fisher C606 
Glacial acetic acid Bio/Bio 
Methanol (HPLC grade) Fisher A452 
Helium gas in lab 
3-aminopropyl column CEL Associates #132-204
Ph# 800-537-9339 
Pearland, TX 
 
                                                 
2 Jones, DP et al.  Glutathione measurement in human plasma:  evaluation of sample collection, storage 
and derivatization conditions for analysis of dansyl derivatives by HPLC.  Clinica Chimica Acta  275, 
175-184 (1998). 
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Other supplies & equipment needed: 
balance tweezers 
1.5 ml eppi tubes (2/sample) ice & ice chest 
vortex mini vortexer 
mini centrifuge HPLC glass vials with springs, inserts & lids 
pipet and tips calculator 
HPLC vial racks  
 
Preparation of Reagents: 
 
A.  Prepare in advance and store at room temp (except preservation & perchloric 
acid solution – store at 4°C). 
 
1.  100 mM boric acid stock solution: 
 Add 0.62 g boric acid into 100 ml HPLC water. 
 
2.  100 mM sodium tetraborate stock solution: 
 Add 2.0 g sodium tetraborate to 100 ml HPLC water.  May need to stir several 
hours to get into solution – may not completely go into solution. 
 
3.  Preservation solution: 
  8 ml of 100 mM boric acid 
  2 ml of 100 mM sodium tetraborate 
  105 mg L-serine 
  5 mg sodium heparin 
  10 mg BPDS 
  20 mg iodoacetic acid 
  gas with helium for 30-45 min, store at 4°C 
 
4.  Perchloric acid solution (10% (w/v), 0.2 M boric acid, 10 µM r-glu-glu): 
  300 ml HPLC water 
  6.2 g boric acid 
  1.38 g r-glu-glu 
  71 ml of 70% perchloric acid 
  adjust to 500 ml total volume with HPLC water 
  gas with helium for 30-45 min, store at 4°C 
 
5.  KOH/tetrahydroborate solution: 
  5.6 g KOH 
  50 g Potassium tetraborate tetrahydrate (K2B4O7 ⋅ 4 H2O) 
  100 ml HPLC water 
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 **Stir for a few hours.  This is a supersaturated solution and will not 
completely dissolve.  Allow solute to settle before using.  Only use liquid layer. 
 
6.  HPLC solvents 
 Acetate stock: 
  272 g sodium acetate trihydrate 
  122 ml HPLC water 
  378 ml glacial acetic acid 
 Solvent A / Acetate buffer (pH=4.6): 
  640 ml methanol 
  200 ml acetate stock 
  125 ml glacial acetic acid 
  50 ml HPLC water 
 Solvent B / 80% (v/v) Methanol 
  800 ml methanol 
  200 ml HPLC water 
 
B.  Prepare weekly and keep at 4°C. 
 
1.  GSH & GSSG standard (50 µM or nmol/ml) 
 for 5 mM GSH solution:   for 5mM GSSG solution: 
 1.51 mg GSH    3.1 mg GSSG 
 500 µL preservation solution  500 µL preservation solution 
 500 µL perchloric acid solution  500 µL perchloric acid solution 
   for 50 µM GSH & GSSG working standards: 
    10 µL of 5 mM GSH or GSSG 
    445 µL preservation solution 
    445 µL perchloric acid solution 
   for 50 µM mixed GSH/GSSG working standard: 
    10 µL of 5 mM GSH 
    10 µL of 5 mM GSSG 
    440 µL preservation solution 
    440 µL perchloric acid solution 
 
C.  Prepare fresh on day of derivitization and keep at room temp. 
 
1.  Iodoacetic acid solution: 
 2 ml HPLC water 
 14.8 mg iodoacetic acid 
 
2.  Dansyl chloride solution: 
 40 mg dansyl chloride 
 2 ml acetone - must prepare in glass tube (acetone will eat through plastic), 
keep in the dark. 
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Procedure: 
 
A.  Preparing samples for homogenization. 
 
1.  Remove cryo tubes with sample from -80°C and keep on ice. 
2.  Wipe excess moisture from cryo tube and weigh on balance.  Record wt. 
3.  Remove tissue from inside cryo tube and place in 1.5 ml eppi tube – close eppi 
tube.   
4.  Weigh empty cryo tube and record wt.  Subtract empty tube wt from tube wt with 
sample to determine the wt of the sample. 
5.  Immediately add 100 µL of preservation solution and 100 µL of perchloric acid 
solution for every 10 mg of tissue (e.g. 20 mg tissue –  200 µL preservation 
solution + 200 µL perchloric acid solution).  Make sure tissue is covered with 
solution, close eppi tube and place back on ice.  Move to next sample. 
 
B.  Homogenization and preparation for derivitization. 
 
1.  Using mini vortexer, homogenize tissue samples in preservation/perchloric acid 
solution.  Be careful not to splash any solution out. 
2.  After each sample is homogenized, add the same volume of preservation solution 
and perchloric acid solution as was added prior to homogenization.  (e.g. 20 mg 
tissue – homogenized in 400 µL  of equal parts preservation & perchloric acid 
solution – add another 200 µL preservation solution  + 200 µL perchloric acid 
solution.  Final volume = 800 µL).  Vortex on standing vortexer (not mini 
vortexer) to mix well. 
3.  Centrifuge tubes at 10,000 x g for 1 minute. 
4.  Transfer 150 µL supernatant to a clean eppi tube.  Store remainder at 4°C.  
Transferred supernatant may stay at room temperature. 
5.  Prepare standards and blank for derivitization. 
 GSH standard:  150 µL 
 GSSG standard: 150 µL 
 mixed standard: 150 µL 
 blank:   75 µL preservation solution + 75 µL perchloric acid 
solution 
 
C.  Derivitization 
 
Day 1 
1.  To the 150 µL supernatant (or standard/blank) add the following: 
 30 µL iodoacetic acid 
 100 µL KOH/tetraborate solution 
vortex and incubate 20 min at RT. (A precipitate will form.) 
2.  Add 150 µL dansyl chloride solution, vortex and keep at RT in the dark 18-26 
hours. 
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Day 2 
3.  Add 250 µL chloroform to extract unreacted dansyl chloride.  (Samples can be 
stored at this point – as is with perchlorate precipitate and chloroform - at 4°C 
until assayed by HPLC) 
4.  Top layer is used for HPLC analysis. 
  
 
D.  HPLC analysis 
 
1.  Install column and prep column according to manufacturer’s instructions. 
2.  Open Glutathione protocol* on HPLC computer.  Make sure autosampler and 
detector are on and programmed correctly (Dr. Wu’s laboratory personnel can 
help).  Make sure plenty of Solvent A & B are present. 
3.  Pipet 50-150 µL of top layer of sample/standard/blank into an HPLC vial.  Screw 
on lid and vortex to remove air bubbles and ensure sample gets to the base of the 
vial. 
4.  Insert vial(s) into the autosampler and start run on computer and autosampler. 
5.  Each sample runs for 45 minutes.  Do not load more than 13 or 14 samples to 
minimize oxidation that may occur with extended time at room temperature. 
 
*Protocol details: 
Detector:  fluorescence, 335 nm excitation, 610 nm emission, gain 1000 
Injection volume: 10 µL 
Flow rate:  1.0 ml/min 
Gradient:  Min  Solvent A  Solvent B 
   0  20   80 
   10  20   80 
   30  80   20 
   35  0   100 
   38  20   80 
   45  20   80 
Peak times: GSH 27-28 min 
   GSSG 32-33 min 
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